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Disease markers discovery depends on identification and quantification. Currently, 
two-dimensional gel electrophoresis (2-DE) coupled with the matrix-assisted laser 
desorption and ionization time-of-flight mass spectrometry (MALDI-TOF MS) and 
the surface enhanced laser desorption/ionization time-of-flight mass spectrometry 
(SELDI-TOF MS) are two of the most commonly using proteomic approaches for 
the identification of disease-associated proteins / peptides. MALDI-TOF MS has 
very high sensitivity and good resolution, but there is no report indicating that the 
MALDI-TOF MS alone can be used for quantitative proteomic or peptidomic 
profiling, and this limits the use of the MALDI-TOF MS in disease markers 
discovery. In this M.Phil, project, a simple and quantitative approach has been 
developed for peptidomic profiling and quantification with the use of MALDI-TOF 
MS. The effects of spotting methods and energy absorbing reagents have been 
systemically evaluated. When using nitrocellulose sandwich spotting method and 
a-cyano-4-hydroxycinnamic acid (CHCA) as the energy-absorbing reagent, the 
values of the coefficient of variation of the measurements of most of the polypeptides 
were less than 17%. After applying a simple size exclusion approach to remove 
high-molecular weight proteins, the established method is capable of profiling and 
quantifying peptides in serum samples with a mass range between 900 Da to 6,000 
Da (m/z). About 100 peptides can be identified and quantified in parallel in a serum 
sample. Subsequent analyses of the serum peptidomic profiles in hepatocellular 
carcinoma (HCC) and chronic liver disease (CLD) patient groups identified four 
peptides of 1,466 Da, 1,772 Da, 2,442 Da and 2,763 Da, which are the potential 
biomarkers for differentiating between HCC and CLD. A classification tree based on 
the serum levels of the 1,466 Da peptide, the 1,772 Da peptide, the 2,763 Da peptide 
and alpha-fetoprotein (AFP) was developed. It could classify the HCC and CLD 
cases with high accuracy (91%). Most of the HCC cases with non-diagnostic AFP 
levels were correctly classified. Taken together, the quantification capability of the 
MALDI-TOF MS has been demonstrated in this project. This study suggests the 
possibility of a general approach to the screening and identification of tumor-specific 















可以定量剖析900 Da - 6,000 Da的血清多肽。透過這個方法，血清樣 
本中約有一百個肽便可以同時被識別和定量。在隨後的肝細胞癌（HCC) 
和慢性肝病（CLD)病人組別中的血清多肽質體硏究中，四個多肽，其 
質量分別爲l，466Da，1,772 D a，2 , 4 4 2 D a和 2 , 7 6 3 Da被識別為有潜 
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C H A P T E R 1 REVIEW OF LITERATURE 
1.1 Peptidomic Research 
1.1.1 Proteomics and Genomics 
Genomic studies have been employed for scientific research for several decades. 
Based on the genomic studies, scientific studies were now migrating to a new era, the 
proteomic era. This approach of study was also called "post-genomic approach" 
(Chich 2001; Tyres and Mann 2003). The term "proteomics" was coined in 1994 by 
Mark Wilkins et. al at Macquarie University in Sydney and defined by Wasinger et. 
al in 1995 in describing the "total protein complement of the genome" (Wasinger, 
Cordweli et al 1995; Wilkins, Sanchez et al 1996; Wilkins, Sanchez et al 1996). 
Unlike the genome, proteome is dynamic, changing from minutes to minutes in 
response to tens of thousands of cellular environmental signals. Proteome is a new 
exciting technique with many applications. It refer to two distinct fields: the 
“functional” and "structural" studies of proteins (Wojcik and Schachter 2000). On the 
other hand, proteomics could also be described as the study of the properties of 
protein, including post-translation modification; expression level; and protein-protein 
interaction etc. (Chich 2001; Aebersold and Mann 2003). 
The genome is the genetic information of every cells in an organism. The 
measurement and analysis of this information is known as genomics. After the 
completion of the human genomic project by HUGO (Human Genome Organization), 
the focus of research is now moving to identify the structures and functions of 
1 
proteins / peptides that produced by specific genes, especially for those disease 
related genes (Chambers, Lawrie et al 2000; Srinivas, Srivastava et al. 2001; Tyres 
and Mann 2003). In contrast to HUGO, HUPO (Human Proteome Organization) aim 
at investigating all the human proteins (Govorun and Archakov 2002). Proteomics is 
an example of a "post-genomic" technology - to get the most out of the technique 
sequences of all the possible proteins encoded by the genome. (Govorun and 
Archakov 2002). The two areas are not only related, but mutually dependent on each 
others, the human genome sequence provides a framework for proteomics (Venter, 
Adams et al 2001). In combining the genomics with proteomics, this could provide 
holistic understanding of disease mechanisms. Regarding the use of proteomic in 
cancer research, which could be employed to identify markers for diagnosis (Srinivas, 
Srivastava et al 2001; Boguski and Mcintosh 2003; Hanash 2003). 
Due to the high complexity of mammalian system, the protein expression analysis is 
important for the study of disease. As the proteins are expressed at specific 
concentration or structure which could not be predicted from RNA analysis. Also, it 
can provide an avenue to understand. 
1.1.2 Peptidomics and Quantitative Profiling 
Peptidomics is quite a new approach in the protein chemistry research field. 
Nowadays, only few articles could be found with respective to this area. For the 
previous decades, many researchers have searched for the biochemical messenger 
molecules that recognize and co-ordinate the regulatory processes, such as peptide 
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hormones; neuropeptides; cytokines; and enzyme inhibitors (Prieto, Kovtoun et al. 
2002). 
Even though the technologies for peptidomics analysis are there but there is still 
room for development. There are number of developments in specialized areas of 
peptidomics, like peptide profiling; mass spectrometric sequencing; and 
quantification by mass spectrometry (Jurgens and Schrader 2002). 
Recently, the combination of 2-dimensional electrophoresis (2-DE) and mass 
spectrometers (MS) are one of the major approaches for proteomic research. These 
technologies are appropriate for protein with mass range from about 10 kDa to 
200 kDa and isoelectric value (pi) between 4 and 10 (Kennedy 2001). However, the 
methodology is not suitable for native peptide and small proteins (Schulz-Knappe, 
Zucht et al 2001). There are no clear-cut definitions to distinguish peptides form 
proteins, in accordance with the International Union of Pure and Applied Chemistry 
(lUPAC), a molecular weight cut-off limit for peptide is 20 kDa (Jurgens and 
Schrader 2002). 
Due to the physio chemical difference of protein and peptide, the approach for 
proteomic research is different from that of peptidomic. For instance, the mobility of 
peptides is higher than that of large proteins. These factors make itself very difficult 
to be focused on gels. Also, the low molecular weight make them difficult to be 
visualized on gels too (Jurgens and Schrader 2002). Besides, the folding pattern of 
peptides is mostly reversible and the low hydrophobicity of the peptides enable them 
easily dissolve in aqueous systems. So most separating technology is liquid; 
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reverse-phase; and ionic exchange chromatography (Schulz-Knappe, Zucht et al 
2001; Wagner, Miliotis et al 2002). 
Another characteristic of peptide that determines the low hydrophobicity is the 
post-translational modification (PTM) like glycosylation and phosphorylation. 
N-terminal pyroglutamylation and C-terminal amidation which could prevent 
peptides from proteolysis (Jurgens and Schrader 2002). 
Regarding the amino acid sequencing identification steps, proteins are too large to be 
analyzed by MS. It needs to be converted to peptides with sequence specific 
proteolytic enzymes. However, the number of possible specific internal cleavage 
sites would decrease when the size of peptides decrease (James 2001). With the 
improved performance of research instrumentations and software for database 
searches, peptides with mass up to 10 kDa have already become amenable for 
analysis (Beavis and Fenyo 2000). 
The analysis of body fluid such as serum, urine, cerebrospinal fluid (CSF) or 
synovial fluid possess methodological advantages when compare to tissue sample 
analysis. As the metabolic changes, including physiological and pathological changes, 
will directly determine the change of proteins or peptides in extracellular fluid 
(Schulz-Knappe, Raida et al. 1996). For peptides in human body fluid which ranged 
from 0.5 kDa to 20 kDa, the size range that plays a pivotal role in many 
physiological processes, which is now available for comprehensive analysis 
(Schulz-Knappe, Zucht et al. 2001). 
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In determining the amount of specific proteins / peptides in a given sample, not only 
the enzyme-linked immunosorbent assay (ELISA) and radioimmunoassay (RIA) 
provide ways for quantitation but also MS (Jurgens and Schrader 2002). It has been 
shown that, MS including the electrospray (Fierens, Thienpont et al. 2000) and 
matrix assisted laser desorption/ionization time-of-flight (MALDI-TOF) (Gobom, 
Kraeuter et al 2000; Tubbs, Nedelkov et al. 2001) could perform quantitative 
measurement of proteins / peptides. There are also reports demonstrating by 
Uttenweiler-Joseph et. al. and Jimenez et. al. that, MALDI-TOF MS could be 
applied in semi-quantitative analysis of complex peptide mixtures (Jimenez, Li et al. 
1997; Uttenweiler-Joseph, Moniatte et al 1998). 
1.1.3 Proteomics and Peptidomic in Medical Research 
Proteomic or peptidomic profiling in medical applications are aim at scanning and 
identifying biomarkers which can be applied in diagnosis and prognosis. The most 
straightforward approach begins with classifying normal clinical samples from 
perturbed ones (Fung and Enderwick 2002). The application of profiling is promising 
for early detection of diseases (Wu, Hu et al. 2002); therapeutic targets identification 
(Hanash, Madoz-Gurpide et al. 2002; Jones, Krutzsch et al. 2002); and 
disease-related antigens identifications (Le Naour, Misek et al. 2001). 
After the qualitative and quantitative analysis of either human body fluid or tissue 
sample extract, the peptide profiling could allow researchers to understand more 
human diseases, such as, diabetes mellitus (DM) (Jurgens and Schrader 2002) and 
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Alzheimer disease (AD) (Rohlff 2000). Especially in disease markers investigations, 
peptide profiling could be applied in cancer classifications in pancreatic cancer and 
chronic pancreatitis (Valerio, Basso et al 2001) and transitional cell carcinoma of 
bladder (Vlahou, Schellhammer et al 2001). 
Peptidomics approach plays a key role in human disease diagnostic analysis. The 
quantitative peptide profiling would facilitate the investigation and identification of 
disease markers distribution patterns and differentiate between disease types and 
disease stages; and between normal and pathological conditions (Jurgens and 
Schrader 2002) 
1.1.4 Application of Quantitative Peptidomic Profiling in 
Cancer Research 
Early detection is very important in cancer control, management and prevention. In 
2001, the Early Detection Research Network of The National Cancer Institute started 
to employ proteomic profiling in discovering tumor markers for cancer detection 
(Verma, Wright et al 2001). Quantitative peptidomic profiling in cancer research 
encompasses the qualitative and quantitative analysis of differentially expressed 
proteins / peptides from malignant; pre-malignant; and normal tissues (Srinivas, 
Srivastava et al. 2001). 
Before the application of proteomic in cancer research, genomic study (RNA 
expression) is the major investigation approach. However the RNA expression 
cannot totally reflect the whole mechanism of carcinogenesis. Proteins / peptides 
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usually undergo PTM in order to carry out their specific function. PTM is important 
for protein stability; activity; location; and turnover. This modification process create 
a great diversity in protein expression which could be gleaned from simple RNA 
analysis (Wang and Hanash 2002). The gene products, proteins, peptides could give 
its specific profile or pattern. It is logical to link up their expression pattern and 
specific types or subtypes of tumors in cancer researches (Poon, Yip et al. 2003). 
After the introduction of 2-DE, cancer researches have been focused on protein 
expressions (Hanash 2000). This has also been facilitated and accelerated by the 
application of MS (Patterson 2000). Recent years, expression of disease related 
proteins，such as, urothelial papillomas; breast; ovary; lung tumors; and liver cancer 
etc. have been identified by proteomic approach (Hirano, Franzen et al. 1995; 
Schmid, Schmitter et al 1995; Bergman, Benjamin et al 2000; Shalhoub, Kem et al. 
2001; Celis, Celis et al 2002). 
The concept of cancer diagnosis in peptide profiling is not just detecting a single 
analyte, but the expression pattern of many individual proteins / peptides (Petricoin 
and Liotta 2003). Peptidomic profiling is a trend for cancer markers development. It 
can be easily implicated to cancer diagnosis. The main target of peptide profiling is 
to obtain peptide signature from cancer samples. The signature allows cancer cells to 
be distinguished from the normal one (Paweletz, Trock et al. 2001). Advancement of 
MS, peptide profiles can be identified quantitatively. The chips; SELDI; MALDI and 
other advanced technologies would put the profiling process in a high-throughput 
manner (Wulfkuhle, McLean et al. 2001). Among the technologies, SELDI-TOF 
technology is potentially an important tool for the rapid identification of proteins / 
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peptides profile and cancer markers (Wulfkuhle, Liotta et al 2003). 
Apart from tumor marker identifications, quantitative proteomic profiling can be 
applied in cancer monitoring after consultation. Therapeutic efficacy and toxicity 
real-time assessment; and drug resistance investigation of patients are the examples 
(Jain 2000; Herrmann, Liotta et al 2001; Liotta, Kohn et al 2001). 
In 2002, Petricoin and Ardekani et. al. firstly reported the use of profiling technique 
in ovarian cancer detections (Petricoin, Ardekani et al 2002). Within the same year, 
Li and Zhang et. al have combined the profiling technique with the bioinformatics 
tools for breast cancer identifications (Li, Zhang et al 2002). Apart from detections 
of cancer, more accurate techniques in differentiating non-cancer cohorts from 
patients with benign disease has been developed (Adam, Qu et al 2002; Petricoin, 
Omstein et al 2002; Qu, Adam et al. 2002). With the development of computing 
technologies, reports show that, artificial intelligence-based algorithms, like artificial 
neural network (ANN) could also assist in distinguish the cancer-related protein 
profile from that of normal one and is useful in early detection of all stages of cancer, 
like ovarian cancer, in general and high-risk populations (Wu, Hu et al. 2002; Poon, 
Yip et al 2003). 
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1*2 Technologies for Peptidomic Studies and Limitations 
Proteomic studies would employ the combination of techniques, including 2-DE; 
imaging analysis; mass spectrometry; amino acid sequencing; and bioinformatics to 
quantify and characterize proteins (Blackstock and Weir 1999). The key steps in 
proteomics are the separation and visualization of protein, which are most commonly 
achieved by 2-DE and MS respectively (Celis, Ostergaard et al. 1998; Anderson, 
Matheson et al 2000; Chambers, Lawrie et al 2000). 
2-DE was introduced in 1975 by Klose, O'Farrell and others (Klose 1975; OTarrell 
1975). The first dimension (namely isoelectric focusing, lEF) of this technique is 
extremely sensitive to the molecular charge of protein and the second dimension 
(Sodium-dodecyl-sulphate polyacrylamide gel electrophoresis, SDS-PAGE) is 
sensitive to the molecular size of protein. In combining the above dimensional 
procedures, a high resolution in protein separations is achieved (Anderson and 
Anderson 2003). 
There are several approaches in utilizing the MS for proteins and peptides analysis 
which include, firstly, analytic peptide-mass fingerprinting; secondly, the de novo 
sequence interpretation; and finally, the comparative analysis of actual spectra with 
predicted spectra of peptide sequences from protein databases (Chakravarti, 
Chakravarti et al. 2002; Boguski and Mcintosh 2003). The major schematic strategy 
was shown as F I G U R E 1. 
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Image analysis of gel 
+ 
Isolation of spots of interest 
+ 
Proteolytic digestion of protein 
+ 
Mass spectrometric analysis of proteolytic fragments 
+ 
Identification of protein (protein mass fingerprinting) 
FIGURE 1: Schematic Strategy of Proteomic Studies 
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Even though the peptidomic technologies in biomedical researches are very powerful, 
there are still limitations. Increase sensitivity and enhance information capturing are 
the major areas that awaiting for improvement. The successful improvement in the 
sensitivity, resolution, and mass accuracy of MS (Shen, Tolic et al 2001); separation 
sciences (Issaq 2001); and cellular proteomic (Rabilloud 2002) will determine the 
speed of proteomic / peptidomic researches. 
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1.2.1 High Performance Liquid Chromatography (HPLC) 
Chromatography is a technique that contains a mobile phase and a stationary phase 
sample mixtures are separated by continuous partitioning between these phase. 
Liquid chromatography (LC) is one of the most widely used methods for separating 
and / or identifying the components of a solution which employs an adsorbent 
column, component in the mixture are separated in a flowing system. It is one of the 
examples that separating "solution" mixture into individual components (Weston and 
Brown 1997). HPLC is an analogue of gas chromatography where the stationary 
phase is packed into a metal column containing liquid; solid; ion exchange resin; or 
porous polymers. The liquid mobile phase is then forced (pumped) through the 
column under pressure. When the analytes is injected into the mobile phase stream, 
the components would be separated and eluted from the column by different 
mechanisms (Swell 1992; Weston and Brown 1997). According to the theory 
introduced by Martin and Synge in 1941, they stated that，"the stationary phase 
required very small particles and hence a high pressure is essential for forcing the 
mobile phase through a column,，，HPLC sometimes would mean "High-pressure 
liquid chromatography" (Meyer 1998). 
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1.2.1,1 Basic Principle 
A classical HPLC instrument consists of a sample injector, a pump, a column, and a 
detector as illustrated in F I G U R E 2 (Weston and Brown 1997). 
The classification of HPLC is commonly based on the retention mechanism, namely, 
adsorption; partition; size exclusion; affinity; and ion exchange. 
For adsorption chromatography, the solutes are equilibrated in an isotropic 
environment, in which the analytes are in contact with both the neutral, solid 
stationary phase and mobile liquid phase simultaneously. Based on the competition 
of analytes between the stationary and mobile phase, and the properties of analytes, 
polar solutes would be retained longer by polar stationary phases, and the non-polar 
stationary phase would retain the non-polar solutes. In accordance with the polarity 
of analytes, components in the mixture would be separated (Weston and Brown 1997; 
Meyer 1998). 
Partition chromatography is similar to that of adsorption chromatography. However, 
in this case, the stationary phase is considered to be neutral liquid instead of solid 
(Weston and Brown 1997; Meyer 1998). 
Size-exclusion chromatography (SEC) is based on the sieving principle. The 
molecular sieve is accounted by the pore size of stationary phase. With the sieving 
effect, components of the mixture would be separated mainly according to their 
molecular size. Component with large size was eluted first 
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f iqu id — Pump Injector Column Detector ^ Dat^ 
Sample 尸 Controller 
F I G U R E 2: Schematic Representation of HPLC Instrument 
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(Weston and Brown 1997; Meyer 1998). 
Affinity chromatography is based on key-lock mechanism, such as antibody-antigen 
mechanism, which is highly specific to retain specific type(s) of molecule (Weston 
and Brown 1997; Meyer 1998). . 
Ion-exchange chromatography (lEC) is based on the principle of opposite attractions. 
It based on the interaction between the charged liquid mobile phase and 
opposite-charged solid stationary phase. The charged molecules in the mobile 
flow-through which is opposite to the solid stationary phase would be retained in the 
stationary phase. Different charged molecules would then be separated (Weston and 
Brown 1997; Meyer 1998). 
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1.2.1.2 Application in Proteomics / Peptidomics Research 
Separation of proteins with special characteristic may come across limitations. For 
those proteins / peptides larger and smaller than 200 kDa and 10 kDa respectively; 
with pi value higher than 9; and hydrophobic are difficult to isolate (Becamel, 
Galeotti et al 2002). However, combining the HPLC and simple one-dimensional 
electrophoresis (1-DE), the problem could be solved. The isolated targets can be 
subjected to MS analysis. This LC-MS/MS approach can obtain efficient separation 
and high sensitivity detection (Mann, Hendrickson et al 2001). 
The application of HPLC proteomic research is quite flexible. The wide range of 
combination in the mode of separation enables the analysis of complex mixture. The 
automatic multidimensional chromatography, would shorten the separation time of 
low abundance peptide from complex protein / peptide mixtures (Haynes and Yates 
2000; Wu, Hancock et al 2003). 
One of the drawbacks of HPLC is the relative inability to visualize sample by from 
simple image inspection. It requires special detection methods. The high 
mobile-phase pressure is a challenge to column fittings and injectors (MacNair, Patel 
et al 1999; Tolley, Jorgenson et al. 2001). The seals, valves and other parts must be 
able to withstand the ultra high pressure. The pressure tolerance limit of the tubing 
and other instrument components must be well studied and checked before 
performing any experiments, otherwise, it may cause safety problems (Xiang, 
Maynes et al. 2003). 
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The high pressure increases the retention ability in chromatography. This may affect 
the separation efficiency in LC (McGuffin and Chen 1997). Besides, the high 
pressure would cause heat dissipation and fractional heating of mobile phase. This 
uneven radial temperature profile of the column increase viscosity of the mobile 
phase which is higher than that of other gas chromatography. This high viscosity 
decreases the diffusion coefficient and high flow resistance, hence flow velocity has 
to be optimized (Seifar, Kok et al. 1997; Meyer 1998). 
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1.2.2 Peptide Gel Electrophoresis 
Nowadays, there are many methods for protein separation in proteomic researches, 
which include direct protein analysis by MS (Link, Eng et al 1999); the use of 
P r o t e i n C h i p T M technology (Merchant and Weinberger 2000); isotope-coded affinity 
tags (ICAT®) (Gygi, Rist et al. 1999); yeast two hybrid (Uetz, Giot et al 2000); and 
phage display system (Smith 1985; Smith and Petrenko 1997). However, 
electrophoresis still remains the core technique for protein analysis. 
Proteins have their charge characteristic depend upon their sequence and their 
three-dimensional structure. They can also exhibit both cationic and anionic 
characteristics. In protein electrophoresis, both the continuous and discontinuous 
buffer system can achieve separation. Continuous buffer system employs a single 
resolving gel for separations. It employs unique buffer for cathode, anode and gel 
preparation. Discontinuous buffer system generally utilizes two buffers for preparing 
stacking and resolving gel. Both the buffers possess different pH and ionic strength 
from the running buffer in electro-reservoirs. Typically, the protein sample and 
stacking gel are prepared with Tris-HCl (pH = 6.8); the resolving gel and running 
buffer are prepared with Tris-HCl (pH = 8.8) and Tris-glycine (pH = 8.3) respectively. 
This buffer system can concentrate the sample between the stacking and resolving 
gels to give a sharp band of proteins and peptides when comparing with the 
continuous system (Andrews 1986; Hawcroft 1997). 
In the development of electrophoresis for proteins / peptides separation, several 
excellent systems have already been invented. However, there are still problems, for 
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resolving peptides below 10 kDa is not sufficient in conventional Tris-glycine-HCl 
SDS-PAGE system. In 1987, Schagger and von Jagow pointed out that, glycine in the 
system would decrease the resolving power of peptides (below 20 kDa) in 
electrophoresis (Schagger and von Jagow 1987). 
They use a discontinuous buffering system by which buffers for anode; cathode and 
gel preparation are different from each other. In this method, additional spacer gel is 
introduced, molarity of buffer is increased and tricine 
(i.e. N-[Tris(hydroxymethyl)-methyl]-glycine), is used as terminating ions instead of 
glycine. This method can yield a linear resolution from 1 kDa to 100 kDa. Which 
allow this system to be distinguished from other well established systems (Laemmli 
1970; Neville and Glossmann 1974; Douglas, Finkelstein et al 1979; Schagger and 
von Jagow 1987). 
Based on the investigation of Schagger and Jogow, there are commercial available 
products for peptide separations. Like those C r i t e r i o n ™ Precast Peptide Gel 
(Bio-Rad Laboratories. USA)，by employing running buffer with 100 mM Tricine, it 
can allow the separation of peptide below 10 kDa with optimal separation range 
between 1 kDa and 40 kDa (BioRad-Laboratories; BioRad-Laboratories 2000). 
1.2.2.1 Basic Principle 
Tricine is different from glycine. Tricine and glycine possess different pKa value of 
9.6 and 8.15 respectively. They behave quite differently in the stacking process of 
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proteins and peptides. Even thought the molecular size of tricine is larger than that of 
glycine, tricine migrate faster than glycine in the stacking gel. Most of the tricine 
molecules are present in migrating anionic form. It provides a higher molecular 
weight sieve particular useful to separate small fragments produced by chemical 
cleavage methods and limited proteolysis (Schagger and von Jagow 1987). 
In Laemmli system (Laemmli 1970), glycine migrate very slowly in the acidic 
stacking gel, it is suitable for stacking large proteins. However, for proteins / peptides 
below 20 kDa, they are not separated from the bulk sodium dodecyl sulphate (SDS) 
(Schagger and von Jagow 1987). Shifting of the upper stacking limit into the low 
molecular mass range proteins is the general principle in peptide gel electrophoresis. 
This can be achieved by raising the ratio of the effective mobility of trailing ion 
compare to the effective mobility of proteins (Anderson, Berry et al 1983; Schagger 
and von Jagow 1987). 
If the electrophoretic velocity of the leading anion is greater than that of the trailing 
ions in the buffer system, stacking occurs (Anderson, Berry et al. 1983). Based on 
different properties of tricine and glycine, the stacking limit will shift to the low 
molecular weight range of proteins when tricine is used instead of glycine (Schagger 
and von Jagow 1987). 
As reported previously, stacking of small proteins in the presence of SDS is difficult 
when compare to larger ones. All the small peptides will form SDS-peptide 
complexes which the sizes and charges are very much similar to that of free SDS 
micelles (Fish, Reynolds et al 1970). Based on this, Myckoff et. al. suggested a 
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methods in decreasing the amount of SDS for peptide separations (Wyckoff, Rodbard 
etal 1977). 
There are several ways for improving the peptide separation. In 1971, Swank and 
Mankers suggested that, increase the acrylamide concentration and cross linkage; 
with the use of urea; increase gel length; increase amount of low-mobility buffering 
ions will increase the effective separation of peptides (Swank and Munkres 1971). 
Increasing the acrylamide concentration of stacking gel (Merle and Kadenbach 1980), 
making the stacking gel alkaline and increasing the acrylamide concentration (Cabral 
and Schatz 1979), employing gradient gel (Douglas, Finkelstein et al. 1979) together 
with increasing the pH to 8.96 by reagent ammediol also could aid in peptides 
separations (Bothe, Simonis et al 1985). 
1.2.2.2 Application in Peptidomic / Proteomic Research 
By employing Tris-Tricine-SDS buffer system, peptides can be separated according 
to their sizes. Some of them are just 14-amino-acid (2 kDa) peptides (Calcutt, Kim et 
al. 1999). After separation, it could be subject to protease digestion (e.g. 
endoproteinase GluC) and MALDI-TOF analysis (Humeny, Kislinger et al. 2002). 
This technique can also assist the traditional 2-DE system. For those spots which 
cannot be clearly separated by 2-DE gels, they can be isolated by peptide gels (Gatti, 
Huang et al. 1999). Moreover, peptide gels can separate DNA-peptide complexes for 
DNA binding protein analysis (Lipps, Ibanez et al 2001). 
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Other techniques can also be used together with peptide gels. After sample extraction, 
protein or peptide mixture was separated by reverse phase HPLC for fractionation. 
Afterwards, the fractionated sample was subjected to peptide gel electrophoresis. 
After blotting, the sample was analyzed by MALDI-TOF MS with peptide mass 
fingerprinting (Anderson, VanSlyke et al. 1997). Generally, this technique can 
provide a good basis for protein separation especially for those low molecular weight 
proteins which cannot be clearly separated by conventional SDS-PAGE. 
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1.2.3 Capillary Electrophoresis (CE) 
Electrophoresis is used to describe the movement of charged particles or molecules 
in a conductive medium under the influence of electric field (Baker 1995; Weston 
and Brown 1997), 
After the work of Michael Faraday in 1833 to 1834, numerous scientists, including 
Hittorf, Helmholtz and Kohlrauch, expanded his finding and generated the concept of 
electrophoresis. They outlined the basic mechanism of electrophoresis and also 
studied the ions' mobility under electric field (Camilleri 1998). 
CE or high performance CE (HPCE) is a evolution of conventional slab gel 
electrophoresis, but unlike the conventional electrophoresis, it dose not require 
supporting medium and analysis can be carry out in free aqueous solution, also, small 
difference in charge contribute largely in the resolution of open tubular CE. It could 
be used to separate various types of large and small sample analytes, such as simple 
molecules; organic and inorganic ions; peptides; proteins; carbohydrates; and nucleic 
acids. CE, from its name, it requires a capillary, usually a silica glass tube with 20 
|im to 100 |im internal diameter. This narrow tube can allow high voltage application 
and rapid heat dissipation (Kuhn and Hoffstetter-Kuhn 1993; Camilleri 1998; 
Tagliaroa, Manettoa et al 1998). 
Regarding the development of CE, Hjerten firstly discovered the use of narrow tube 
(300 |Lim internal diameter) in 1967 for electrophoresis in reducing the thermal effect 
(Hjerten 1967). Three years later, Neuhoff et. al. had carried out electrophoresis with 
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a narrow glass tube (450 jum internal diameter and 3 cm long) that filled with 
polyacrylamide gel for minute quantities of protein (Neuhoff, Schill et al 1970). In 
1979, Mikkers performed free zone CE in a Teflon® tube with 200 i^m internal 
diameter (Mikkers, Everaerts et al 1979). Starting from 1980s, Jorgenson and 
Lukacs are the first group of scientist who demonstrated CE with <100 |Lim internal 
diameter capillary (Jorgenson and Lukacs 1981; Jorgenson and Lukacs 1983). Later 
on, the use of CE for biomolecules analysis has increased dramatically till nowadays 
(Camilleri 1998). 
1.2.3.1 Basic Principle 
The general instrument of CE consists of four parts. A capillary for separation of 
analytes; a high voltage direct current (DC) power supply; a detector for determining 
the presence and amount of separated analytes; and a safety interlock-equipped 
enclosure for protecting the operator from high voltage. FIGURE 3 gives a 
schematic representation of the basic instrumentation of CE. CE is inherently a 
microchemical technique. After preparing a CE column, and completing the circuit 
with buffer solution and platinum electrodes, analytes will be introduces into the 
capillary. Under the application of high DC voltage (usually 35W), analytes will be 
separated by different mechanisms. An optical window is located at the other end of 
the capillary, and usually ultra-violet (UV) light beam is focused radically into the 
center of the tube. Electronic signals will be collected and analysed for the collection 




High Voltage Ground  
Power supply “ ^ 
f  






广 \ ) 
\ ！ ) 
Capillary for 'Capillary for ] 
running buffer .sampie injection Detector 
injection _ r^ 
Anode | 1 I Cathode 
• ^ J ： \ y \ y \ A • V V • 
I Source Vial Sample Vials | | Destination Vial ] 
Sample tray 
FIGURE 3: Schematic Representation of Capillary Electrophoresis 
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There are several modes of operation in CE, the separation can be carried out based 
on different physical-chemical principles. It could be simply achieved by just 
changing the buffer and/or capillary. The modes of operation include, capillary zone 
electrophoresis (CZE); capillary gel electrophoresis (CGE); micellar electrokinetic 
capillary electrophoresis (MECC or MEKC); capillary chromatography (CEC); 
chiral capillary electrophoresis (chiral CE), capillary isoelectric focusing (cIEF); and 
capillary isotachophoresis (cITP) (Baker 1995; Weston and Brown 1997; Tagliaroa, 
Manettoa et al 1998). 
CZE is the simplest form of CE. Buffer solution is flushed through the capillary by 
pressure. Sample is then injected and high voltage is applied. Each sample molecules 
will migrate through the capillary on their own speeds. Separation is based on 
difference in the electrophoretic mobility of the solutes, resulting in different 
velocities of migration of ionic species in the electrophoretic buffer contained in the 
capillary. Ideally, sample mixture will be separated from each other forming 
individual zones of pure materials. However, natural molecules cannot be separated 
by this method as they migrate at the velocity of electroosomotic flow (EOF) which 
is a foundation factor that driven the CZE (Baker 1995; Tagliaroa, Manettoa et al. 
1998). 
CGE is an adoption of traditional slab gel electrophoresis to capillary format. Its 
separation mechanism is based on molecular size difference which is similar to 
simple classical gel electrophoresis including slab SDS-PAGE; agarose gel or 
polyacrylamide gel electrophoresis. The gel substance acts as a nonconvective 
medium for molecular sieving and separate analytes according to their molecular size 
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(Baker 1995; Weston and Brown 1997; Tagliaroa, Manettoa et al 1998). 
MECC is introduced by Terabe et. al (Terabe, Chen et al. 1994), this technology can 
resolve natural and charged molecules. The main mechanism is based on 
"chromatography-like mode” solute partitioning between the micellar phase and the 
solution phase. Micelles are aggregate of amphophilic monomers (known as 
surfactants) which possess hydrophilic heads and hydrophobic tails. The heads can 
be cationic; anionic; zwitterionic; or nonionic. When the surfactant molecules exceed 
their critical micelle concentration (CMC), they will be pushed together by the polar 
medium. Micelles serve as a pseudo-stationary phase that similar to the stationary 
phase in reverse phase HPLC as mentioned. EOF acts as the chromatographic mobile 
phase. Generally speaking, the more polar molecules migrate faster than less polar 
and hydrophobic molecules (Baker 1995; Weston and Brown 1997; Plaut, Girod et al 
1998). 
In CEC, the capillary is packed with chromatographic packing which can retain 
solutes. The separation mechanism is based on normal distribution which depends on 
particular type of conventional chromatography. The stationary phase would be the 
packing materials of the capillary whereas the mobile phase is driven through the 
capillary by EOF (Weston and Brown 1997; Deyla, Mikika et al. 1998). 
Chiral-CE plays a major role in chiral molecules separation. The separation 
mechanism is based on the stereo specific, hydrophobic interaction between chiral 
molecules and chirally active selectors. These selectors possess an external 
hydrophilic surface, and hydrophobic cavity towards enantiomers. Free selectors are 
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natural and hydrophilic, consequently migrate at the same speed of the EOF. After 
combining the chiral molecules, due to size difference, the migrating velocity will be 
different from that of the native selectors. Among the enantiomer-selector complexes, 
enantiomers with higher affinity towards the selectors would have lower overall 
electrophoretic mobility, thus, lower migrating velocity. Finally enantiomers can be 
isolated from each other (Weston and Brown 1997; Fanali, Aturki et al. 1998). 
The separation mechanism of cIEF is mainly based on the isoelectric value (pi) of 
molecules which is similar to conventional lEF. It requires a complex buffering 
system forming a pH gradient between the two electrodes. Ampholines / zwitterionic 
compounds with pi varying in a pH range are added to the buffer which fills up the 
capillary. After dipping the electrodes into appropriate buffers (cathode to basic 
buffer and anode to acidic buffer) and completing the circuit, the ampholines will 
migrate inside the capillary until reaching their isoelectric points. Once reaching the 
points, pH gradient between the ends of capillary will be established. Samples 
proteins will then be focused themselves with respective to their pi value. After 
focusing step, the immobilized bands are moved towards the detector by 
hydrodynamic mode for analysis (Baker 1995; Weston and Brown 1997; Tagliaroa, 
Manettoa et al. 1998). 
cITP resembles classical isotachophoresis (ITP). ITP is also known as multizonal 
electrophoresis or displacement electrophoresis. The separation mechanism is based 
on a discontinuous buffer system. However, it is different from that of conventional 
ITP, it requires no carrier electrolytes. The sample molecules to be analyzed will be 
sorted and sandwiched between the leading and terminating (trailing) electrolytes. In 
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the buffering system, the ions of leading and terminating electrolytes possess highest 
and lowest mobility respectively. After electric field is applied, the samples begin to 
sort themselves in zones in accordance with their mobility. For those ions with higher 
mobility have higher conductivity, thus have lower field strength across the zone and 
velocity decreased. Finally, based on the mobilities (i.e. complex and intrinsic 
function of molecules which influenced by molecular mass; charge; shape; and 
degree of salvation of molecules), ionic mixture can be separated (Baker 1995; 
Weston and Brown 1997; Tagliaroa, Manettoa et al 1998). 
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1.2.4 Mass Spectrometry 
Mass spectrometers provide a fertile ground for the development of new technology 
and applications that have far reaching effects in the physical, chemical and 
biological sciences�The development of “soft ionization" techniques (they do not 
degrade the molecule during the ionization process) over the previous 30 years, that 
allow the mass spectrometry widely employed in biological science (Matsuo and 
Seyama 1994). The soft ionization methods include, Matrix-assisted Laser 
Desorption/Ionization (MALDI) (Karas and Hillenkamp 1988); electrospray 
ionization (ESI) (Govorun and Archakov 2002; Aebersold and Mann 2003) and fast 
atom bombardment (FAB) (Morris, Panico et al. 1981). 
Since the early 1980s, mass spectrometry has become an important strategy in 
determining the primary structure of proteins and peptides. At the same time, there 
were numbers of techniques that were possible to ionize large polar molecules like 
peptides with few hundred kDa (Biemann 1994) 
A mass spectrometer is an analytical instrument that can separate charged molecules 
according to their mass-to-charge ratios {m/z). By definition, it consist of firstly an 
ion source; secondly a mass analyzer that measure the m/z of the ionized analytes; 
and also a detector that registers the numbers of ions at each m/z value (Aebersold 
and Mann 2003). 
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1.2.4.1 Electrosprav Ionization (ESI) Mass Spectrometry 
Electrospray ionization (ESI) is one of the soft ionization methods. It has been 
known for over a century. The first experiment on ESI was carried out by Seville 
Chapman in late 1930s in investigating the mobility of ions created from spray and 
bubbling of aqueous solution with the use of Erikson mobility tube (Chapman 1937; 
Chapman 1938; Chapman 1938). In the late 1960s, Dole and his co-workers 
developed a practical method of sample ionization for mass spectrometry (Dole, 
Mack et al. 1968; Clegg and Dole 1971). In the 1980s, Fenn et. al. discovered the 
multiple charging phenomenon which lead to the development of modem-day 
technique of elecrtospray ionization mass spectrometry (ESI-MS) for the ionization 
of biological macromolecules and polymers (Yamashita and Fenn 1984; Fenn, 
Mann et al 1989) 
1.2.4.1.1 Basic Principle 
ESI is a method to produce gaseous ionized molecules from a liquid solution by 
creating a fine spray of droplets in the presence of a strong electric field. 
Elecrtospray itself is not an ionization process, it is just a process that transferring the 
analytes in condensed phase to gas phase as isolated entities (Gaskell 1997). There 
are four major processes in ESI. Firstly, the charged droplets production. Secondly, 
the droplets shrinkage by solvent evaporation and droplet disintegration. Thirdly, the 
production of gas-phase ions. Finally, secondary process by which gas-phase ions 
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were modified in the atmospheric and ion sampling regions (Kebarle and Tang 
1993). 
In generating gas phase molecules, analytes solution is passed through a capillary 
that is highly charged by electrostatic field (up to 20 kV) resulting in formation of 
highly charged and fine liquid micro-droplets (i.e. aerosol) (Gaskell 1997; Govorun 
and Archakov 2002). 
When the solvent of analyte was emitted out from the capillary it will experience an 
electric field that maintaining by the high potential of the tip. The ions in liquid 
analyte will be drifted toward and accumulated on the surface which will then be 
drawn toward a counter electrode and lead to the formation of "Taylar Core”，After 
the formation of the Taylar Core, when the surface tension of the liquid exceed by 
the applied electrostatic force, "budding" will occur that lead to evaporation of 
analyte and formation of droplets (Wilm and Mann 1994). 
The droplets will fly through a pressure gradient, due to surface area decreases, like 
charges at the droplet surface become increasingly close together, they will decrease 
in diameter with collisional wanning preventing freezing. Until the magnitude of the 
charges is sufficient enough to overcome the surface tension that holding the droplet 
(i.e. reaching the Rayleigh Limit), Coulomb Explosion (droplet subdivision resulting 
from high charge density) occur. Eventually, like-like Coulombic repulsion of 
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charges leads to disintegration of droplet into smaller droplets. Continuous depletion 
of micro-droplets by further fission or ion evaporation may lead to formation of 
single ion micro-droplets or gas phase ions. The charged molecules are ready for MS 
analysis at this moment (Iribame and Thomson 1976; Gaskell 1997). F I G U R E 4 
gives the schematic representation of ESI MS. 
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1-2.4.2 Matrix-assisted Laser Desorption/Ionization 
Time-of-Flight rMALDI-TOF) Mass Spectrometry 
MALDI-TOF MS was introduced in the year of 1987-1988 by Karas et al. (Karas, 
Bachmann et al. 1987; Karas and Hillenkamp 1988) and, Tanaka and his coworkers 
(Tanaka, Waki et al 1988). 
1.2.4.2.1 Ionization of Samples 
Beginning with sample preparation, the peptide sample after specific protease 
digestion (refer to T A B L E 1 for classical protease in peptide digestion) (Richards 
1998), would firstly be ionized. To generate gas phase, protonated molecules, a large 
excess of matrix chemical is coprecipitated with molecules of peptide sample by 
mixing a submicroliter volume of the mixture and sample onto a metal substrate and 
allowing it to dry. The matrix chemicals are typically a small organic molecules with 
absorbance at the wavelength of the laser employed. (Refer to T A B L E 2 for the 
matrix chemicals that employed in MALDI assay). Matrix chemicals differ in the 
amount of energy they impart to the biomolecules during desorption and ionization 
and hence the degree of fragmentation that they cause. 
The matrix chemical molecules of the resulting matrix-analyte solid co-crystals will 
absorb the energy from the laser light by nanosecond (ns) laser pulses, which 
generated from nitrogen lasers with a wavelength of 337 nm (UV), and transfer it 
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Protease Cutting Site(s) 
Clostrdium histolyticum Arg-C C-terminal of arginine 
Lysobacter enzymogenes Lys-C C-terminal of lysine 
Papaya proteinase IV C-terminal of glycine 
Pseudomonas fragi Asp-N N-terminal of asparatate 
Staphlococcus aureus Vg C-terminal of glutamate 
Trypsin C-terminal of lysine and arginine 
























































































































































































































































































































































































































































































































































































































































































































































































































































into excitation energy of the solid system. Thereby, inducing an instantaneous phase 
transition of small molecular layers of the sample into a cloud of gaseous species. In 
the expanding gas cloud, all ions ablated from the sample plate have nearly the same 
velocity of about 500 m/s and a distribution half-width of approximately 100 m/s 
(Hillenkamp, Karas et al 1991). During the expansion of this gas cloud, protons and 
ions like NaC are exchanged between the analyte (often a protein) and the matrix 
chemical molecules. That will mainly lead to the formation of single-positive 
charged analyte molecules (Zenobi and Knochenmuss 1999). 
The ions formed are accelerated in a strong electric field, with typical accelerating 
voltages of approximately 15 kV to 25 kV. After passing a charged grid, the 
molecules drift freely over a field-free space, which is for most MALDI-TOF 
spectrometers in the range of 0.5 m to 3 m. The length of this field-free TOF 
pathway influences the achievable mass resolution: ions of low mass arrive at the 
detector faster than those of higher mass; consequently ions of different masses can 
be separated. An appropriate recorder at the end of the flight tube produces a signal 
upon the impact of each ion group (Hillenkamp, Karas et al. 1991; Patterson 2000). 
There are several advantages for using MALDI-TOF MS for protein identification, 
which include high accuracy (in linear mode, the error was < +0.05% for angiotensin 
and myoglobin; in reflector mode the error was < ±0.01o/o for ACTH (clip 18-39) and 
E. Coli. thioredoxin), little consumption of sample, and short measurement time etc. 
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1.2.4.2.2 Time-of-Flight (TOFi Analyzer 
The first time-of-flight (TOF) instrument was introduced and commercialized by 
Wiley and McLaren in 1955 (Wiley and Mclaren 1955) 
There are several kind of analyzers, including Quadmpole; Ion Trap; TOF 
(Burlingame, Boyd et al. 1998); Fourier Transform (Buchanan and Hettich 1993) and 
Magnetic Sector etc. (Johnstone and Rose 1996). 
Here we only talk about the TOF analyzer. TOF a means that ions are resolved in the 
time domain before they collide with a detector. The TOF mass analyzer would 
measure the elapsed time from acceleration of the charged (ionized) molecules 
through a field-free drift region. The ions are formed by laser pulse shooting at the 
target with a duration usually from 1 ns to few ns. The ions are accelerated by a 
potential difference (V). Typically, a voltage of 20 kV is placed on the sample plate 
at the back of the source. The drift regions one cm to two cm and the drift length (D) 
is longer then 1 m, the time of flight (t) of the drift region can be approximately 
given by the following equation (Cotter 1997; Patterson 2000). 
/mass t = J xD 
V 2eV 
Typically, the mass analyzer that couple with MALDI is a TOF tube mass analyzer. 
TOF has the advantages of compatibility with pulsed laser techniques, which include 
rapid data acquisition, relatively inexpensive hardware because a magnetic field is 
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unnecessary, low ion wastage, and, above all, no insurmountable upper mass limit 
(Cotter 1997). 
The schematic representation of the MALDI-TOF mass spectrometer was shown in 
FIGURE 5 (Griffin and Smith 2000; Schiller and Arnold 2000; Patterson, Aebersold 
et al 2001). 
1.2.4.2.3 Application in Peptidomic / Proteomic Research 
The MALDI-TOF technique can be used on protein identification and 
characterization (Joubert, Stmb et al 2001); protein glycan structure identifications 
(Westphal, Kolarich et al. 2003); polypeptides partial sequencing (Pineiro, Vazquez 
et al 2001); DNA mutation detections (Sun, Hung et al. 2002); enzyme activity 
monitoring (Petkovic, Muller et al 2002); protein profiling (Molloy, Phadke et al 
2002); triacylglycerol products (Hlongwane, Delves et al. 2001) and 
single-nucleotide polymorphisms (SNPs) (Ross, Hall et al 2000) quantitative 
analyses etc. 
With the invention of soft-ion technology, and the development of MALDI-TOF MS, 
peptidomic / proteomic research in the biological science would be fastened 
afterwards. 
In quantitative peptidomic profiling, the MALDI source allows direct proteins 
identification by peptide mass fingerprinting and high quality tandem MS data 
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FIGURE 5: Schematic Representation ofMALDI-TOF Mass Spectrometer 
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acquisition to be made possible (Medzihradszky, Campbell et al 2000; Shevchenko, 
Sunyaev et al 2001). The new development of tandem MS/MS instrument to 
MALDI source, which benefit the sensitivity, and productivity of proteins / peptides 
identifications (Bienvenut, Deon et al. 2002). 
One of the non-2-DE-based techniques is stable-isotope labelling analysis. This 
would be presented below (Gygi and Aebersold 2000). 
\2A.2A Isotope-Coded Affinity Tags flCAT®) 
Apart from Enzyme-linked immunosorbent assay (ELISA) or radioimmunoassay 
(RIA) which provide precise quantitation of protein concentration especially for low 
abundant proteins / peptides (Lill 2003). The current approach of combining 2-DE 
and MS is good for protein characterizations and quantitations. Regarding most of 
the ionization methods, MALDI, has been reported as a method for giving good 
quantitation and ICAT® is one of the assisting techniques (Preston 2002; Oda, Owa 
et al 2003). 
In relative protein quantitation, there are several approaches, including 2-DE; 
metabolic isotopic labeling; chemical labeling of specific proteins; and differential 
mass mapping. ICAT® is one of the chemical labeling (modification) methods in 
quantitative proteomics. Other chemical labeling methods include ^^ O incorporation 
during enzymatic cleavage (Stewart, Thomson et al 2001; Yao, Freas et al. 2001; 
Reynolds, Yao et al 2002); Acid-labile isotope-coded extractants (ALICE) (Qiu, 
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Sousa et al 2002); lysine-specific labeling (Berger, Lee et al 2002; Gu, Pan et al. 
2002); phosphoresine- and phosphothreonine-specific labeling; N-terminus labeling 
like, nicotinyl-N-hydroxysuccinimide; acylation (Ji, Chakraborty et al. 2000); 
amidation — quantitation using enhanced signal tags (QUEST) (Beardsley and Reilly 
2003)]; and C-terminus labeling by esterification with methanol and ^Hs-methanol 
(Goodlett, Keller et al 2001) (Lill 2003). 
In chemical labeling, it targets the thiol group of amino acid, cysteine, of proteins or 
peptides. In addressing this issue, commercial available ICAT® reagent (Applied 
Biosystem, Framingham, MA) is employed as the key chemical (Lill 2003). The 
structure of ICAT® reagent consists of 3 functional elements, namely the 
thiol-specific reactive group; the deuterated / non-deuterated linker group; and the 
biotin group. The structure of ICAT® molecule is shown in FIGURE 6 (Gygi, Rist et 
al 1999; Smolka, Zhou et al 2001). 
The thiol-specific group is selectively applied to the sulphydryl group in the side 
chain of cysteine of proteins or peptides, which allow the ICAT® molecule 
covalently attached to cysteine residue in every protein. The ethylene glycol linker 
occurs in 2 distinguishable forms: the deuterated (d8, isotopically heavy), and 
non-deuterated (dO, isotopically normal) which contain eight deuteriums and no 
deuterium respectively. Finally the biotin group act as affinity tags for selective 
isolation of tagged peptides from the mixture of digested peptides via avidin affinity 
chromatography (Gygi, Rist et al 1999; Smolka, Zhou et al 2001). 
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Heavy Reagent: d8-ICAT (X=deuterium) 
� Light Reagent: dO-ICAT (X=hydrogen) 
\ / 0 X X 0 
\ s xZ xZ 
X X 
Biotin Linker (heavy or light) Thio-specific 
Reactive Group 
FIGURE 6: Structure oflCAT® Reagent 
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In starting the ICAT® assay, two extracted protein mixture from two different cell 
states would be purified and treated with the stable isotopically heavy or light ICAT® 
reagent respectively. After complete labeling, the two mixtures would be mixed and 
subjected to enzymatic digestion (usually proteolyzed by Trypsin or Lys-C) into 
peptides. After digestion, the tagged-peptides would be separated and purified by 
multi-dimensional chromatography. The sample complexity was reduced by strong 
cation exchange chromatography (SCX), for removing the remaining protease, 
unreacted ICAT® reagents, and SDS. After increasing the purity of samples, the 
tagged-peptides (cysteine containing peptides) were fractionated and separated from 
mixture via avidin affinity chromatography as mentioned above. The purified 
tagged-peptides was subjected to microcapillary reverse phase liquid 
chromatography (jaLC) elecrtospray ionization (ESI) tandem MS (MS/MS) or 
MALDI analysis (Gygi, Rist et al 1999; Han, Eng et al 2001; Pattern, Schulenberg 
et al 2002; Ranish, Yi et al 2003). 
Peptide quantitation is based on either peak areas or signal intensity analysis, or the 
combination of both. In this step of analysis, as mentioned, the difference between 
the dO-ICAT® and d8-ICAT® reagent is eight mass units, the ICAT®-labeled peptides 
would appear as paired signals with eight mass unit difference. Numerous paired 
peak areas would be compared for the determination of peak area ratio of dO:d8, thus, 
the relative quantity of specific peptide could then be calculated. In selecting the 
specific peptide ion of particular m/z for collision-induced dissociation (CID), the 
peptide sequence information would then be obtained (Han, Eng et al 2001). 
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In combining the above information (the peptide identification and relative quantity), 
the change in relative abundance of specific peptide / protein with respective to 
specific cell stage could be studied. For schematic representation of ICAT® strategy, 
please refer to FIGURE 7 (Gygi, Rist et al 1999; Han, Eng et al 2001; Ranish, Yi 
et al. 2003). 
1.2.4.2.5 Limitations 
Proteins / peptides analysis by MALDI-TOF MS suffers from some disadvantages 
like short sample life time and strong dependence on the sample preparation methods 
and low shot-to-shot reproducibility (Sze, Chan et al 1998). In sample preparation, 
it relies heavily on purification procedures prior to MALDI analysis. After proteolytic 
digestion, the peptides would be extracted together with non-volatile buffers and 
salts. The presence of these salts interfere the subsequent MS analysis. The 
purification steps do not lead themselves to automation easily. The additional 
desalting and purification procedures also account for cost raising in analysis (Chin 
and Papac 1999; Sauer, Lechner et al. 2000). As reported by Mock et. al (Mock, 
Sutton et al 1992), there are common contaminants which may adversely affect 
MALDI spectra of peptides and proteins. The effects include signal suppression, 
erratic signal production, and peak broadening (causing by cationization; adducts, 
and consequent requirements for increasing laser power). Any adverse effects will be 
very much dependent on the choice of matrix chemicals and samples (Sze, Chan et al 
1998). 
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Cell state 1 Cell state 2 
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3 (iLC-HPLC 
I 
MS analysis by ESI or 
MALDI MS 
^ ‘ ^ 
Relative peptide Peptide / protein 
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FIGURE 7: Schematic Representation of IC AT® Strategy 
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One weakness that limit the application of ICAT® is that the labeling process of 
cysteine containing proteins require appropriately spaced protease cleavage sites 
(Haynes and Yates 2000). As reported by Berggren et. al., the ICAT® assay failed to 
detect four out of the eight subunit of Escherichia coli (E.coli.) FI -FQ -ATP synthase 
(Berggren, Chemokalskaya et al 2001). Besides, it is only suitable for the detection 
of cysteine containing protein or peptides, however, in some cases, like E.coli., the 
overall proteins containing no cysteine is high, that is about 10% to 15% (Patton 
2002). So not all protein quantitation is suitable for the application of ICAT® reagent. 
However, this problem may be overcome by substituting other chemical labeling 
methods as mentioned above. 
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1.2.4.3 Surface Enhanced Laser Desorption/ionization 
(SELDI) Mass Spectrometry 
SELDI-TOF is a novel approach introduced by Hutachens and Yip in the year 1993 
(Hutchens and Yip 1993). There are 3 major components in the system: 
ProteinChip™ arrays; a mass analyzer; and data analysis software (Issaq, Conrads et 
al 2003). 
1.2.4.3.1 Basic Principle 
Among the 3 components, the ProteinChip™ (Cephergen Biosystems, Fremont, CA, 
USA) is the heart of the system which allows SELDI to be distinguished from other 
MS-based systems (Fung, Thulasiraman et al. 2001; Issaq, Veenstra et al 2002). 
Similar to those traditional chromatographic technologies, the ProteinChip™ arrays 
are made of different chromatographic surfaces. The ProteinChip™ array are made of 
10 mm wide x 80 mm long aluminum strip with eight or sixteen 2 mm spots with 
biochemically active surfaces (receptors; immobilized antibodies; enzymes; DNA 
and etc.) or chemically active surfaces [reverse phase (H4); metal ions (IMAC3); 
hydrophobic (CI8); hydrophilic (SiO�)； anionic (SAX2); cationic (WCX2); and etc.] 
(Wright, Cazares et al 1999; Bane, LeBlanc et al 2002; Govomn and Archakov 
2002; Goldstein, Muffat et al 2003; Issaq, Conrads et al 2003; Mannes, Martin et al. 
2003). 
According to different properties of the active surfaces (general or specific 
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physiochemical), specific type of proteins were retained on the surface (Chapman 
2002). Generally, the chemically active surfaces would retain whole class of protein. 
Whereas the biochemically active surfaces would interact and couple specifically 
with single target protein, like those biochemically activate antibodies. 
Based on the properties of the SELDI system, it could selectively capture target 
proteins from complex biological samples. It could be used to exploit specific 
molecular recognition mechanisms, like receptor-ligand; antibody-antigen; 
enzyme-substrate; and protein-DNA interactions. It could be also used for 
assessments of modification sites; and studies of functional activity. The selectivity 
of chemically active surfaces could be used for protein or peptide profiling (Forde 
and McCutchen-Maloney 2002; Issaq, Conrads et al 2003). 
After selecting the right ProteinChip™, sample mixture or pure protein preparation 
was incubated with the chips. The residual materials (unbound proteins) are then 
removed by serial washing steps with varying stringencies of pH, salts, organic 
solvents or buffers. After the surface was dried, energy absorbing molecules 
equivalent to MALDI matrix chemicals ( T A B L E 2), is added to the chip arrays. The 
chip array is then ready to subject to the "on-chip" laser desorption mass analysis for 
weight based protein profiling (Wright, Cazares et al. 1999; Fung, Thulasiraman et al. 
2001) 
After the sample is digitalized, the data was analyzed by specific software from 
Cephergen Biosystems. The software could convert the MS peaks into 1-DE images, 
which is known as "gel view”. In addition, the software could also perform cluster 
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analyses to identify significant differences in relative protein abundance across many 
samples (Govorun and Archakov 2002). Compare to MALDI-TOF MS, SELDI-TOF 
MS is limited in its ability in protein identification. The schematic representation of 
SELDI analysis is shown in FIGURE 8. 
1.2.4.3.2 Application in Peptidomic / Proteomic Research 
SELDI analysis of biological samples could be employed in biomarkers discovery. 
The markers discovered include infectious and inflammatory diseases; 
cardiovascular diseases; neuropsychiatry; and cancer etc. (Fung, Wright et al 2000; 
von Eggeling, Davies et al 2000; Hampel, Sansome et al. 2001; Johnston-Wilson, 
Bouton et al 2001; von Eggeling, Junker et al 2001) 
It possess advantages over other proteomic techniques, like 2-DE (Wulfkuhle, Liotta 
et al. 2003). It can facilitate rapid discovery and identification of tissue-specific 
disease markers (Shiwa, Nishimura et al. 2003). It can assay the disease status of 
cancer, benign hyperplasia, and normal states of prostate (Yasui, Pepe et al. 2003). 
Many potential diagnostic markers like those for prostate cancer (Wright, Cazares et 
al 1999), bladder (Vlahou, Schellhammer et al 2001), breast (Wulfkuhle, McLean 
et al 2001)，and ovarian (Petricoin, Ardekani et al. 2002) cancers; Alzheimer's 
disease (Austen, Frears et al. 2000) can be studied. It can also be applied to the 
identification of phosphorylated and glycosylated proteins (Cardone, Roy et al. 
1998), transcription factors and peptides and proteins secreted by cancer cell lines 




























































































































































































































































































































































































































































































































1.2.4.3.3 Retentate Chromatog;raphy (RCi 
Retentate chromatography aims at capture, purify, characterize and identify proteins 
of interest on a ProteinChipTM. it is performed on ProteinChipTM Arrays with varying 
chromatographic properties, as mentioned above (Fung and Enderwick 2002). The 
target protein and / or the impure components that remain bound to the solid-phase 
chromatographic surface (i.e. the ProteinChip™ arrays) are referred to as the 
"retentate". The term Retentate Chromatography-Mass Spectrometry (ROMS) 
refers to the key elements of the technique which select sample binding / desorption 
on functionalized surfaces followed by mass spectral analysis of retained 
components (Weinberger, Viner et al 2002; Poon, Yip et al 2003). 
The ProteinChip™ system is a unique integration of state-of-the-art chromatographic 
separation techniques and TOF MS on one platform (Surface-enhanced Laser 
Desorption/Ionization (SELDI)-TOF-MS). The affinity coated ProteinChips™ allow 
washing off "noise" (non-bound proteins, salts, detergents etc.) before analysis by 
TOF-MS. The technique can be described as RC-MS or a high-sensitivity 
high-throughput affmity-MALDI. Key benefits are ease-of-use, fast results (hundreds 
of samples can be run in a few days), low sample volumes, high sensitivity and high 
reproducibility (Santambien, Brenac et al. 2002; Weinberger, Boschetti et al. 2002). 
The wide ranges of applications of retentate chromatography include protein 
profiling, protein-protein interaction studies and basic protein characterization 
including the possibility of doing on-chip protein identification make it a very 
versatile and strong tool for proteomics research today. New techniques like PAID 
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(Proteolytic Amplification for Identification and Detection) are developing (Dare, 
Davies et al 2002; Weinberger, Boschetti et al. 2002). 
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12.4 4——Recent Advances in the Application of MALDT 
Technolo2;ies 
MALDI usually couple with TOF analyzer for protein identification and quantitation. 
However, due to the advancement of technology, MALDI was combined with other 
analyzers and energy source to expand its performance. 
Post-source decay (PSD) provides information for structural identification like amino 
acid sequencing. It relies on metastable decomposition or fragmentation of 
laser-desorbed ions. The process takes place in the field-free drift region of the 
reflector TOF MS to produce daughter ions from selected parents. It is a very 
powerful tool in identifying PTM or chemically induced modification of proteins / 
peptides. However, it is a method of low sensitivity and mass accuracy (Gevaert, 
Demol et al. 1997; Spengler 1997; Chaurand, Luetzenkirchen et al 1999). 
MALDI-TOF/TOF follows the footprints of MALDI-TOF instrument. It provides 
ideal focusing for ion acceleration form the first source region. The TOF/TOF 
instrument is composed of three functional components, namely the ion selection; 
collision region; and fragment detection (Medzihradszky, Campbell et al. 2000). It's 
configuration is an alternative method for the PSD methods (Loboda, Krutchinsky et 
al. 2000). It can obtain better mass accuracy for daughter ions in the range of 100 
ppm (Medzihradszky, Campbell et al. 2000; Vestal, Juhasz et al. 2000). When 
compare to simple PSD, it gives high-energy collision-induced dissociation (CID) 
spectra of peptides that superior to PSD spectra (Medzihradszky, Campbell et al. 
2000). 
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Inside the instrumentation, the first mass analyzer is located between the first ion 
source and timed ion selector (TIS). The TIS consists of two gates, which will 
selectively deflect two types of ions with two specific mass ranges. When ion 
mixture passes through the TIS, only ions of the intermediate mass are allowed to 
pass through the gate and migrate to the collision region (Vestal, Juhasz et al. 2000). 
The collision region is filled up by collision gases and is equipped with small 
negative charged guide wire. This would transmit the intermediate ions into 
low-energy fragment ions which would be analyzed by second TOF analyzer. The 
analyzer provide high-resolution spectra of the fragmented ions (Medzihradszky, 
Campbell et al 2000). 
MALDI Quadrupole/Time-of-flight (MALDI Qq-TOF) employs a collisional 
damping interface usually with mass resolving power of 10,000 (full width at half 
maximum, FWHM) and accuracy in the range of 10 ppm. The major advantage of 
this configuration is the selection of parent ions in the quadmpole mass filter prior to 
the injection of TOF analyzer for separation and detection. The fragmentation is 
caused by CID and resulting ions are then mass analyzed in the final mass analyzer 
as product ions. It allows flexible degree of fragmentation which is better than that of 
PSD and benefit the peptidomic researches (Loboda, Krutchinsky et al. 2000; 
Verhaert, Uttenweiler-Joseph et al. 2001). 
Cylindrical Ion-trap (IT) (Grebner and Neusser 1994); quadmpole IT (QqlT) (Chien, 
Michael et al. 1993); and segmented ring trap (Qinchung, Davenport et al 1996) 
have been interfaced with TOF MS. Another application of MALDI is to combine IT; 
QIT; or quadmpole ion-trap/reflectron (QqlT/re) with TOF MS. (i.e. MALDI-IT-TOF 
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MS; MALDI-QqIT-TOF MS; or MALDI-QqIT/re-TOF MS). It provides new 
possibilities for trapping ions (Lee and Lubman 1995; Doroshenko and Cotter 1998). 
Apart the mode of detection, there is modification in the MALDI energy source. UV 
is usually employed in MALDI MS (Chalmers and Gaskell 2000). However, Infrared 
(IR) can act as an alternative to UV which is emitted at frequency 337 nm and 2.94 
i^m respectively (Patterson, Aebersold et al 2001). Reported by Burlingame and 
co-workers, the IR source in MALDI produce less spontaneous fragment of 
phosphorylated and glycosylated peptides when compare to UV MALDI MS 
(Cramer, Richter et al 1998). Not only alternatives in energy sources could be found 
in MALDI MS, but also different mode of sample ionization. Krutchinsky and Zhang 
et. al. have coupled a swithcable ion source (electrospray and MALDI) with a 
Qq-TOF analyzer. They act as partners and could mutually compensate others 
limitation (Krutchinsky, Zhang et al. 2000). 
In the modification of analyzer, the TOF tube has integrated with mass correlated 
acceleration (MCA) technology. Not only the technique will benefit the focusing step 
but also would decrease the size of spectrometer. The length of the whole analyzer is 
just ten cm (four inch) long. The MCA could increase resolving power for wider 
mass range when compared with pulsed extraction. The miniaturized MALDI-TOF 
MS accurately determine the molecular weight of peptides for identification. The 
resolution is sufficient enough for the biomarker detection and medical diagnosis 
(Prieto, Kovtoun et al. 2002; English and Cotter 2003). 
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C H A P T E R 2 OBJECTIVES 
Compared to proteomics, peptidomics is a field that is much less well developed. 
High-throughput technologies for comprehensive quantitative analysis have been 
lacking. Recent advances for peptidomic analysis include the MALDI-TOF MS 
technology and the SELDI-TOF ProteinChip™ technology. Numbers of research 
studies have recently proved the high-throughput and quantitative nature of the 
SELDI-TOF ProteinChip™ technology. Through the profiling of the serum peptides 
and proteins, the SELDI-TOF ProteinChip™ technology is especially useful in the 
discovery of proteomic / peptidomic patterns for the detection of various cancers. 
There were reports of research studies in which the MALDI-TOF MS was applied in 
the discovery of disease-associated peptides. The quantitative nature of MALDI-TOF 
MS is not well established. It was regarded as a semi-quantitative technology. Indeed 
the SELDI-TOF ProteinChip^^ technology is very similar to the MALDI-TOF MS 
technology, except that the former one includes a retentate chromatographic hydrogel 
surface for selective capture of a specific group of proteins/peptides based on their 
physio-chemical properties. Both technologies require energy absorbing chemical to 
donate protons to the peptides / proteins under the activation of laser, and both 
technologies measure the mass of a molecule by measuring their time-of-flight (TOF) 
from the sample plate to the detector. 
As most of the typical proteomic laboratories have equipped the MALDI-TOF MS 
instrument for protein identification, it will be valuable if new methodology is 
developed to allow people to use MALDI-TOF MS for quantitative peptidomic and / 
or proteomic profiling. 
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The first objective of this project was to develop a methodology to make use of 
MALDI-TOF MS for quantitative measurement of peptides and proteins. The second 
objective of this project was to develop a simple method for direct profiling of 
peptides in a serum sample with the use of new MALDI-TOF MS method from the 
first objective. Using HCC as a cancer model, the third aim of this project was to 
identify potential peptidomic patterns for cancer diagnosis by quantitative 
peptidomic profiling. 
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C H A P T E R 3 METHODOLOGIES 
The research project was divided into method development and identification of 
distinguishing features for HCC. 
3,1 Method Development 
3.1.1 Nitrocellulose (NO Preparation 
Hybond C nitrocellulose (NC) membrane (Amersham Biosciences, Piscataway, NJ) 
was cut into small pieces and dissolved in acetone to 2% w/v. The solution was then 
diluted with same volume of isopropanol to form the 1% stock solution. Different 
concentrations of NC solution (0.01%, 0.05%, 0.1%, 0.25%, 0.5% and 1.0%) were 
prepared from 1:1 (v/v) acetone-isopropanol solution. 
3.1.2 Matrix Chemicals Preparation 
Saturated CHCA solution was prepared by dissolving Img of CHCA with 250 jiL of 
50% acetonitrile (ACN) containing 0.3% trifluoroacetic acid (TFA; Sigma, St Louis, 
MO). Then the solution was diluted 4 times with 40% ACN, 0.1% TFA. Typical 
sinapinic acid (SA) was dissolved with 30% ACN and 0.2% TFA to concentration of 
1 |LLg/mL. 
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3.1.3 Spotting Methods 
Three types of spotting methods were employed and summarized as below: 
Direct mixing method: 1 i^L of sample was mixed with 1 jiL of matrix chemical, the 
2 j^ L sample/matrix chemical mixture was then spotted onto the sample plate and 
allowed to dry. 
Overlaying method: 1 juL of sample was directly spotted onto the sample plate 
surface and allowed to dry. 1 juL of matrix chemical was then overlaid onto the 
sample afterwards. 
Sandwich method: 1 |LIL of NC solution (0.01%, 0.05%, 0.1%, 0.25%, 0.5% and 1.0%) 
was first spotted onto the sample plate using a positive displacement pipette and dry 
completely in air. 1 \xL of matrix chemical was spotted and 1 \xL of sample was added 
afterwards. Finally 1 fiL of matrix chemical was spotted on top of the sample. 
The methods are summarized in TABLE 3. 
3.1.4 Standard Preparation 
Protein standards were prepared from the Sequazyme'^^ Peptide Mass Standard Kit 
(Applied Biosystem, Foster city, CA). Components of the standard mixture were 


























































































































































































































































































































































































Peptide / Protein Theoretical Average Concentration  
Standard Mass, MH+ (pmol/^L) 
1 Des-Arg-Bradykinin 905.05 LOO 
2 Angiotensin I 1,297.51 3.30 
3 Glu-Fibrinopeptide B 1,571.61 1.30 
4 ACTH (clip 1-17) 2,094.46 2.00 
5 ACTH (clip 18-39) 2,466.72 1.50 
6 ACTH (clip 7-38) 3,660.19 3.00 
7 Insulin (bovine) 5,734.59 4.50 
8 Thiroedoxin {E. coli.) 11,674.48 5.50 
9 Apomyoglobin (horse) 16,952.56 8.00 
10 Bovine serum albumin 66,431.00 2.40 
11 IgG (mouse) 148,500.00 6.00 
TABLE 4: List of the Standard Peptides Used in this Experiment 
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3.1.5 Data Collection and Analysis 
All the samples were detected by the Voyager DE™-Pro MALDI-TOF MS (Applied 
Biosystem). The MS was operated in positive mode and the laser power was 
optimized for different matrix chemical. During optimization of matrix chemical and 
spotting methods, low- (600 Da to 12,000 Da) and high- (10,000 Da to 200,000 Da) 
molecular weight proteins were detected by different settings to achieve better 
resolutions. Each measurement was repeated ten times. Serum peptides of m/z 
between 900 and 6,000 were measured five times for each sample. All the detections 
were automatic, each spectrum was the result of 35 laser shots and 104 spectra were 
collected at different positions for each spot (total 3,640 scans). The MS was 
operated with the Voyager Instrument Control Panel Software (Version 5.10, 
Applied Biosystem) and, the raw spectrum data was analyzed with the Voyager Data 
Explorer Software. (Version 4.0.0, Applied Biosystem). The spectra were collected 
and accumulated without setting any biases or limitations. Results were expressed as 
percentage of total peak area, or relative peak intensity based on the calculations 
below: 
n . _c*T� r» 1 A Peak Area of the Interested Peak ,…， Percentage of Total Peak Area = = x 100% 
^ (Peak Area) 
D 1 o 1 T + •“ Peak Area of the Interested Peak . Relative Peak Intensity = x 100% 
Peak Area of an Internal Reference Peptide 
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3.2 Identification of Distinguishing Features for HCC 
Serum samples (healthy and disease group) were collected from volunteers with prior 
consent, and were stored at -20 before use. AFP serum levels were quantified by 
microparticle EIA (MEIA, Abbott Laboratories, Chicago, III., USA). Twenty |LIL of 
serum was mixed with peptide standards (Applied Biosystem) as an internal control 
and inactivated with 60 jiiL of 1% TFA solution. The mixture was then fractioned 
with a 30 kDa cutoff Microcon centrifugal filter device (Millipore, Billerica, MA) 
according to the manufacturer's instructions. The flow through fraction was collected 
and spotted onto the sample plate coated with 0.1% NC by the sandwich spotting 
method using CHCA as matrix chemical. 
Pooled serum of two disease groups (Serum AFP concentrations more than 500 
ng/mL and AFP concentration less than 500 ng/mL) and control serum (chronic liver 
disease, CLD) were compared in pilot experiments. Potential features were then 
verified in sera from different individuals (18 CLD samples, 18 HCC samples with 
serum AFP concentration < 500 ng/mL and 18 HCC samples with serum AFP 
concentrations > 500 ng/mL). 
3.2.1 Classification Trees 
The classification and regression tree algorithm was applied in the study (Breiman, 
Friedman et al. 1984; Milkier, Franthal et al 1998; Ridley, Jones et al. 1998). The 
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study groups (HCC serum AFP more than or less than 500 ng/mL and CLD control 
samples) were the objects of the prediction. The protein markers and serum AFP 
concentration are the predictors and were used to define tree structure. The 
construction is based on information-theoretic concepts and proceeds as follows: 
1. Construction of a large tree, in which the data determine a hierarchy of 
cutoffs for the predictors such that each split has the greatest information 
content; 
2. Pruning, branches containing "negligible" information is removed. S-Plus 
(version 4.5, a statistical software, MathSoft, Cambridge, Mass., USA) was 
used to develop the classification trees. Serum AFP and markers levels were 
used as input variables for generating classification tree models. The 
classification tree serves to provide a user-friendly system based on as few 
variables as possible for diagnosis. 
3.2.2 Statistical Analysis 
Spearman's rank correlation was used to calculate the distance, and relationship 
among different markers between the study groups. SPSS for Windows (version 10.0, 
a statistical software, Chicago, USA) was employed for the analysis tool. 
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C H A P T E R 4 RESULTS 
4.1 Optimization of Spotting Methods in Protein 
Quantification 
Quantitative and reproducibility of a detection system are very important for protein 
quantitation when using MALDI-TOF MS. These qualities are especially dependent 
on efficient laser desorption. Thus, a method that allows samples to form 
homogenous crystalline matrix chemical is a prerequisite. 
Initial attempts were made to find out a good combination of sample spotting method 
and matrix chemical that can give quantitative and reproducible results. Three types 
of spotting methods were employed in the study (TABLE 3). Direct mixing method 
was the original spotting method developed for MALDI-TOF MS. Overlaying 
method allows spotting of samples and matrix chemical separately; this method is 
especially useful when the MALDI sample plate is used as a device for collecting 
HPLC fractions. For the nitrocellulose (NC) sandwich spotting method, NC was first 
used by Preston (Preston, Murray et al 1993) on MALDI sample plate to give a 
more homologous sampling surface. 
To test for the quantitative ability and reproducibility of different sample spotting 
methods, a mixture of commercially available protein standards was used as the 
analytes; there are ten different proteins present in the standard mixture, with 
molecular weights ranging from 905 Da to 148,500 Da (TABLE 4). The protein 
standards were spotted with different methods and with two different matrix 
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chemicals (CHCA and SA). 
Each sample was detected twice with different acquisition protocols to achieve better 
resolution for low- (600 Da to 12,000 Da) and high- (10,000 Da to 20,000 Da) 
molecular weight proteins. The acquisition protocol scans 104 different positions on 
the sample plate surface in a spiral motion, and the software was set to accumulate 
all the spectra without setting any limitations or biases. Thus, the final spectrum 
gives a general picture of the analytes in the sample well. This method averages out 
the effect of "sky-high signal" hot spots and spots with very low signal intensities. 
Minimum manual handling is needed and these measures are very important for 
signal quantification and system automation. 
4.1.1 Detection of Low-Molecular Weight Proteins / 
Peptides 
TABLE 5 summarizes the detection results for low-molecular weight proteins and 
peptides. Overlaying method gave the poorest results. Largest values of standard 
deviations (SD) and coefficient of variations (CV) were observed, especially when 
detecting proteins larger than 3,500 Da (ACTH (clip 7-38) and insulin). The CVs of 
the direct mixing method were greater than 20. 
When using the NC sandwich spotting methods, smallest CV values could be 
obtained when compared with direct mixing or overlaying method. The pre-coated 























































































































































































































































































































































































































































































































































































protein-matrix crystals with similar sizes and also form an even surface on the metal 
sample plate (Miliotis, Marko-Varga et al 2001). When concentrations of coating 
NC decreased, there was an increasing trend of and CVs. The data suggest that the 
amount of NC coating on the sample plate affects crystallization. 0.1% NC gave the 
best results (CVs < 17%) among the three different concentrations of NC used. 
When the NC density was too low, the effect of "crystallizing network，，might reduce, 
resulting variable crystals which were spreading unevenly on the sample plate 
surface. Higher nitrocellulose concentrations were also applied (> 1.0%), but the 
peak intensity fell significantly (data not shown). When using high concentrations of 
NC, some proteins might have physically bound to the nitrocellulose network (e.g. 
by non-covalent molecular binding forces). 
In direct and overlaying spotting method, crystals might be variable sizes and did not 
form evenly onto the sample plate surface. Consequently, some signals might exceed 
the detection limit of the MS detector, so the quantification of proteins became 
difficult. It is clear that homogenous sample preparation will generate signals with 
relatively lower values of CV when compared to non-homogenous preparations. 
When using SA as the energy-absorbing agent, no calculable peak was obtained in 
detecting low-molecular weight proteins (less than 10,000 Da) regardless of the 
spotting methods. This indicates that the matrix chemical is not suitable for 
transferring energy to small proteins. This observation is consistent with other groups 
finding in which SA was not a good matrix chemical for low-molecular weight 
proteins and peptides (Beavis and Chait 1990). The effect of using matrix chemical 
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mixture (1:1 mixture of CHCA and SA) was also investigated, however, no 
satisfactory results could be generated (data not shown). 
4.1.2 Detection of High-Molecular Weight Proteins 
In detecting high-molecular weight proteins with CHCA as matrix chemical 
(TABLE 6); and SA as matrix chemical (TABLE 7), the relative peak area as a 
percentage of an internal reference peak, thioredoxin from E. coil appeared to be a 
better expression of the results. The data showed that decreasing concentrations of 
NC correlated with increasing values of CV. Similar to the results of low-molecular 
weight proteins, 0.1% NC gave the best results among the three different 
concentrations of NC used. Except the overlaying spotting method, mouse IgG was 
not detected in all the CHCA spotting methods. It is consistent to the fact that CHCA 
is not a good matrix chemical for ionizing high-molecular weight proteins 
(> 10,000 Da) (Kussmann, Lassing et al 1997). 
When using SA as matrix chemical, all the protein standards including mouse IgG 
were ionized and detected. However, in general, the results were less quantitative, 
compared to those obtained with the use of CHCA. The CV values were rather large. 
CV values for mouse IgG measurement were > 40%. None of the spotting methods 
resulted CV values < 20% for all the studied proteins of size < 67 kDa. 
As described above, CHCA sandwich method with 0.1% NC gave the best results for 
profiling proteins / peptides of mass < 66.5 kDa. This nitrocellulose-MALDI-TOF 
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I . ,• 
. , � ‘‘ 
MS (NC-MALDI-TOF MS) approach therefore was employed in the following 
experiments. 
f 













































































































































































































































































































































































































































































































































































































































































































































































































































4.2 Assay Linearity of the Nitrocellulose-MALDI-TOF MS 
for Peptides with Different Masses 
The assay linearity of the NC-MALDI-TOF MS method was performed in parallel 
with quantification of peptides of various mass values. The spotting optimization 
experiments indicated that the NC-MALDI-TOF MS was a better choice for 
quantification of peptides. The assay linearity experiment focused on peptides of m/z 
values between 900 Da - 6,000 Da. ACTH (clip 18-39) or glu-fibrinopeptide B was 
used as the internal reference peptide, and added to the samples at a fixed 
concentration. By keeping the concentration of the reference peptide constant, the 
performance of the MALDI-TOF MS in quantitation of a mixture of peptides was 
examined. 
FIGURE 9 and 10 show that typical mass spectra for quantitative analysis of 
peptides. Using ACTH (clip 18-39) (2,466.7 m/z) as the internal reference peptide, 
the peak intensities of des-arg-bradykinin (905.1 m/z), angiotensin I (1,297.5 m/z), 
glu-fribinopeptide B (1,571.6 m/z�, and ACTH (clipl-17) (2,094.5 m/z) increased 
with increasing concentrations of the respective peptides. Using glu-fibrinopeptide B 
as the internal reference peptide, similar findings were observed when measuring the 
intensities of ACTH (clip 1-17) (2,094.5 m/z), ACTH (clip 18-39) (2,466.7 m/z), 
ACTH (clip 7-38) (3,660.2 m/z) and insulin (5,734.6 m/z) (data not shown). 
Calculated as a percentage of the peak area of the reference peptide, the relative 
intensities of des-arg-bradykinin (FIGURE 11), glu-fribinopeptide B (FIGURE 12), 
ACTH (clip 1-17) (FIGURE 13), ACTH (clip 18-39) (FIGURE 14), ACTH 












































































































































































































































































































































































































































































































































































































































































































































































































































































































































































































































































































































































































































































































































































































































































































































































































































































































































































































































































































































































































concentrations. When fitted with quadratic function, all R^ values were equal to or 
higher than 0.98. These results demonstrate that the measured intensity is directly 
proportional to the quantity of the peptide regardless of the mass. 
As a concluding remark, within the selected mass range (900 — 6,000 m/z), the assay 
linearity was satisfactory with R^ values > 0.98 for all the tested peptides of different 
masses. Therefore the combined use of NC sandwich spotting method and 
MALDI-TOF MS is useful in quantitative profiling of a peptide mixture. So far, this 
study provides the first clear evidence that the MALDI-TOF MS can be used directly 
in quantification and profiling of complex peptide mixture. 
4.3 Accuracy of Mass Measurement 
The accuracy and precision of the NC-MALDI-TOF MS method in obtaining the 
peptide mass values were examined. The results are summarized in TABLE 8. For 
the assessed mass range from 900 Da to 6,000 Da, percentage errors for all the tested 
standard peptides were less than 0.05%. All CVs were less than 0.03%. 
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Theoretical Mean of Masses from 
Peptide / Protein average Mass, 5 Independent assay, [e^entage � y (o/。）  
^ ^ ^  
Des-Arg-Bradykinin 
905.05 904.68 0.041 0.025 
(905.5 Da) 
Angiotensin I 
1297.51 1297.18 0.025 0.024 
(1297.5 Da) 
Glu-Fibrinopeptide B ，、 
^ ^ 1571.61 1571.35 0.017 0.026 
(1571.6 Da) 
ACTH (clip 1-17) 2094.46 2094.32 0.007 0.025 
(2094.5 Da) 
ACTH (clip 18-39) ^466.72 2466.68 0.002 0.025 
(2466.7 Da) 
ACTH (clip 7-38) 3560.19 3660.26 -0.002 0.025 
(3660.2 Da) 
Insulin (bovine) 5734.59 5734.95 -0.006 0.025 
(5734.6 Da) 
TABLE 8: Summary of the Accuracy and Precision of Measurement of the Masses for the 
Peptide Standards by NC MALDI-TOF MS 
The masses shown were obtained from 5 independent assays 
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4.4 Application in Quantitative Peptidomic Profiling of 
Serum 
Serum was used to test if the approach could be applied in the quantitative 
peptidomic profiling of biological samples. Serum is chosen because it is rich in 
physiological information (physiology indicators and disease markers) (Hanash, 
Brichory et al 2001; Miller, O'Dowd et al 2001). Unprocessed serum from a healthy 
normal donor was used for the pilot study, but it failed to generate any signals at the 
peptide range. The major proteins in serum (e.g. albumin) might have competed with 
other peptides / polypeptides in the ionization process. The effect of removal of 
proteins of mass greater 30 kDa on the peptidomic profiling was examined. To 
remove these high-molecular weight proteins and to reduce the sample complexity, 
the samples were allowed to flow through a 30 kDa cutoff filter. TFA was added to 
stop the biological activities in the serum by acidification. Peptide standards were 
added to the serum before the processing steps, and served as internal standards for 
mass calibration and quantification. 
FIGURE 17 shows a representative spectrum of the serum sample after removal of 
proteins of mass > 3 0 kDa. In the mass range of 900 Da to 6,000 Da, there were 
about 100 peptides identified in the serum sample. The inter-assay error of the 
quantitative profiling was investigated. The assay was repeated in five different days. 
Relative peak areas of some of the peaks were shown in TABLE 9. The CVs for the 
measurements of all the peptides are less than 15%, indicating the NC-MALDI-TOF 



























































































































































































































































































































































, Coefficient of Variation (CV, %) 
Average Mass {m/z)  
Percentage of Total Peak Area Relative Peak area 
~ 1,206,65 146 l85 
2 1,260.57 5.24 6.23 
3 1,350.59 10.00 11.57 
4 1,466.47 2.60 2.76 
5 1,617.60 3.67 5.12 
6 1,830.87 4.59 5.74 
7 1,897.02 12.65 11.37 
8 2,029.36 9.50 10.41 
9 2,112.35 4.85 4.55 
10 2,210.17 14.29 13.34 
11 2,489.07 4.68 6.64 
12 2,553.24 5.87 4.55 
13 2,933.10 7.50 5.98 
14 3,274.74 14.55 14.66 
15 3,530.76 5.5 9.91 
16 3,680.02 4.40 5.86 
17 3,704.09 11.41 13.09 
18 5,004.78 7.45 8.85 
TABLE 9: Inter-assay (Between Days) Errors of Quantitative Measurement of 18 Representative 
Peptides Identified in the Serum Sample 
number of measurement = 5, and each in duplicated 
Summary of some representative peaks identified in the serum sample. The signal intensities were 
normalized with the total peak area or with the peak area of the internal reference, ACTH (clip 18-39). 
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4.5 Application in Tumor Marker Discovery 
4.5.1 Identification of Peptidomic Features for 
Classification Between the HCC and CLD Patients 
by Classification Trees Analysis 
Individual serum samples from 18 CLD controls and 36 HCC patients (18 with AFP 
< 500 ng/mL and 18 with AFP > 500 ng/mL) were subjected to quantitative 
peptidomic profiling with the use of the NC-MALDI-TOF MS method and CHCA as 
matrix chemical. About 100 peptides were observed in each serum samples. 
Classification tree analyses were performed to identify the diagnostic peptidomic 
patterns for differentiating between HCC and CLD cases. 
Two classification tree models were generated. For the first model, the intensity 
values of the serum peptides were neglected. When a peptide was observed in a mass 
spectrum, “1” was assigned to be the peptide abundance. When a peptide was absent, 
“0” was assigned to be the peptide abundance. Using this approach, three peptides 
with mass values of 1,466 Da, 1,772 Da and 2,763 Da were identified and used for 
classification between HCC and CLD (FIGURE 18). 29 out of 36 HCC and 16 out 
of 18 CLD cases were correctly classified, resulting a sensitivity of 81%, a 
specificity of 89% and an overall accuracy of 83%. Among the HCC cases with 
non-diagnostic serum AFP level (< 500 ng/mL), 16 out of 18 were correctly 
classified. 
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( ^ a t i e n t ^ 
0 , 1 
一 Feature 1，466 m/z — 
OJ ^ 11 
一 Feature 1，772 m/z — 
0 1 
~ Feature 2,763 m/z ~ 
HCC CLD CLD CLD 
FIGURE 18: The Pruned ^^Qualitative" Classification Tree 
Generated from the presence or absence of various potential serum markers identified in the study 
for classification of the CLD (n-18) and HCC cases (n=36). “0” indicates the feature was not 
detected, “1” indicates the presence of the distinguishing feature. 
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For the second classification model, the continuous values of the relative intensities 
of each peptides identified in the serum samples were used to develop a classification 
tree to differentiate between the HCC and CLD cases. FIGURE 19 shows the 
resulted "quantitative" classification tree. Two peptides of 1,772 Da and 2,442 Da 
were finally included in the classification tree. 35 out of 36 HCC and 13 out of 18 
CLD cases were correctly classified, resulting in a sensitivity of 97%, a specificity of 
72% and an overall accuracy of 89%. Among the HCC cases with non-diagnostic 
serum AFP level (< 500 ng/mL), all 18 samples were correctly classified. 
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( ^ a t i e n t ^ 
Feature 1，772 m/z 
，r 
YES ^ NO 
p ~ Feature 2,442 m/z <22 — ~ 
X 1 2 1  
HCC CLD CLD 
FIGURE 19: The Pruned ^^Quantitative" Classification Tree 
Generated from serum level of various potential serum markers identified in the study for 
classification of the CLD (n-18) and HCC cases (n=36). 
^ — peak intensity percentage relative to internal reference 
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4.5.2 Serum Levels of the Diagnostic Peptides in the HCC 
and CLD Patient Groups 
From the classification tree analyses, four peptides with masses of 1,466 Da, 
1,772 Da, 2,442 Da, and 2,763 Da were identified as the potential biomarkers for 
classification between HCC and CLD. The 1,772 Da peptide was the only one 
included in both of the classification tree models. TABLE 10 summarizes the levels 
of these four peptides in the HCC and CLD groups. The levels of the 1,466 Da 
peptide were significantly higher in the HCC group whereas the levels of the 
1,772 Da peptide and the 2,442 Da peptide were significantly higher in the CLD 
group. FIGURE 20 to 24 show the scatter plots for the quantities of identified 
peptides. 
4.5.3 Spearman^s Rank Correlation Analysis of the 
Diagnostic Peptides and AFP 
TABLE 11 and 12 summarize the results of the correlation analyses among the 
serum levels of diagnostic peptides and AFP. APPENDIX 1 to 16 show the 
experimental data in detail. In both the HCC and CLD groups, the serum level of the 
2,442 Da peptide was positively correlated with serum level of the 2,763 Da 
peptide. No other significant correlation was identified in the HCC and CLD groups. 
There was no correlation between the serum AFP level and the serum level of any 
diagnostic peptides. These results suggest that the clinical values of the diagnostic 
peptides identified in this study do not significantly overlap with that of AFP. 
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Average mass HCC CLD /;-value 
(m/z) (n = 36) (n = 18) (HCC vs. CLD) 
1,466 7.4 ± 11.5 0 0.013 
1,772 1.2 ±4.0 27.0 ±52.4 0.002 
2,442 4.7 ±8.0 12.3 ± 15.2 0.022 
2,763 4.1 ± 7 . 6 10.0 ±15 .4 0.100 
TABLE 10: The Levels ± SD of the 4 Identified Peptides 
They were identified in the classification tree analyses as the potential diagnostic biomarkers, 
in the HCC and CLD patient groups. The peptides levels were measured as a relative 
intensity of the peak area with the use of peak 2,446 m/z as the internal reference. The 
Mann-whitney rank sum test was used to compare the peptide levels between the two study 
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Features (m/z) 2,442 2,763 AFP level 
1,772 -0.088 -0.274 0.230 
(0.729) (0.271) (0.359) 




TABLE 11: Table Showing the Relationship between Markers in CLD Cases (n=18) 
Figures in bold indicates the correlation coefficient between markers and p values are 
bracketed. The pair of variables with positive correlation coefficients and p value below 0.05 
tends to increase together. For the pairs with negative correlation coefficient and p values 
greater than 0.05, there is no significant relationship between the variables. 
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Features {m/z) 1,772 2,442 2,763 AFP level""“ 
1,466 0.210 -0.165 -0.097 -0.120 
(0.219) (0.335) (0.575) (0.484) 
1,772 -0.219 0.032 0.057 
(0.199) (0.851) (0.739) 




TABLE 12: Table Showing the Relationship between Markers in HCC Cases (n=36) 
Figures in bold indicates the correlation coefficient between markers and p values are bracketed. 
The pair of variables with positive correlation coefficient and p value below 0.05 tends to 
increase together. For the pairs with negative correlation coefficients and p values greater than 
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FIGURE 20: Scatter Plot Showing the Quantities of 1,446 Da Serum Peptide in CLD Cases (n=18) 
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FIGURE 21: Scatter Plot showing the Quantities of 1J72 Da Serum Peptide in CLD Cases (n=18) 
and HCC Cases (n=36) 
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FIGURE 22: Scatter Plot Showing the Quantities of 2,442 Da Serum Peptide in CLD Cases fa二 18) 
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FIGURE 23: Scatter Plot Showing the Quantities of 2 J63 Da Serum Peptide in CLD Cases (n-18) 
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FIGURE 24: Scatter Plot Showing the Quantities of AFP in CLD Cases ( n = m and HCC Cases 
(n=36) 
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4.5.4 Combined Use of the Diagnostic Peptides and AFP in 
the Diagnosis of HCC 
As the correlation analysis suggests that there is no significant overlapping of the 
clinical values of the identified diagnostic peptides and AFP, it is logical to predict 
that combined use of the diagnostic peptides and AFP should be able to increase the 
accuracy in the classification between the HCC and CLD cases. 
In the first approach, serum AFP level was used as diagnostic criterion in additional 
to a classification tree. The diagnostic criteria for being an HCC cases were that 
either the serum AFP level was higher than 500 ng/mL or the cases was classified as 
an HCC case by one of the classification tree models. When serum AFP was 
included in the diagnostic criterion in addition to the classification tree basing on the 
1,466 Da peptide，the 1,772 Da peptide, and the 2,763 Da peptide, the overall 
accuracy was increased from 83% to 91%. TABLE 13 shows the result. 
In the second approach, the serum AFP level, and the serum levels of the four 
diagnostic peptides were used to construct the classification tree. AFP, the 1,466 Da 
peptide, the 1,772 Da peptide, and the 2,763 Da peptide were included in the final 
classification tree model (FIGURE 25). 35 out of 36 HCC and 13 out of 18 CLD 
cases were correctly classified, resulting in a sensitivity of 94%, a specificity of 83% 
and an overall accuracy of 91% (TABLE 13). Among the HCC cases with 
non-diagnostic serum AFP level (< 500 ng/mL), 16 out of the 18 cases were correctly 
classified. All these results strongly suggests that the 1,466 Da peptide, the 1,772 Da 
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peptide, and the 2,763 Da peptide are potential markers for diagnosis of HCC, and 
could be used in combination with AFP to achieve better diagnostic accuracy. 
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Diagnostic Model Sensitivity (%) Specificity (%) Accuracy (%) 
AFP > 500 ng/mL 50 (18/36) 94 (17/18) 65 (35/54) 
Classification tree Model 1 
81 (29/36) 89 (16/18) 83 (45/54) 
(m/z 1,466; 1,772; 2,763)* 
Classification tree Model 2 
97 (35/36) 72 (13/18) 89 (48/54) 
(m/z 1,772; 2,442) 
Classification tree Model 1 
94 (34/36) 83 (15/18) 91 (49/54) 
OrAFP>500 ng/mL 
Classification tree Model 2 
94(34/36) 67 (12/18) 85 (46/54) 
OrAFP>500 ng/mL 
Classification tree Model 3 
94 (34/36) 83 (15/18) 91 (49/54) 
(AFP, m/z 1,466, 1,772, 2,763) 
TABLE 13: Comparison of Diagnostic Values of the Conventional AFP Test and the Three 
Classification Trees for Differentiating HCC Patients (n=36) and CLD Patients (n-18) 
The figures in parentheses are n/total n. ^Classification biomakers included in the classification tree 
model are shown in the bracket. 
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} r 
YES ^ NO 
一 Feature 1,772 m/z <18 一 
1 r 
YES NO 
I — AFP <500 ng/mL 
YES I ^ NO 
Feature 1，466 m/z <4 
^  
YES ^ NO 
j — Feature 2,763 m/z <5 一 
CLD HCC HCC CLD HCC 
FIGURE 25: The Pruned Classification Tree Composed of the Serum AFP and Serum 
Peptidomic Features 
Generated from serum level of various potential serum markers identified in the study and serum 
AFP level for classification of the CLD (n=18) and HCC cases (n=36). 
朵=peak intensity percentage relative to internal reference 
105 
C H A P T E R 5 DISCUSSION 
Proteomics is the study of protein properties that results in a universal and 
incorporated view of an organism, tissue, or single cell at the protein level 
(Blackstock and Weir 1999). Important physiological regulators are usually present 
in extremely low amounts and are very difficult to discover or detect. Unlike nucleic 
acid that can be amplified by Taq polymerase in polymerase chain reactions (PGR), 
proteins and peptides do not have equivalent reactions and for amplification. Thus, a 
device that has high sensitivity, good resolution and ability to measure the amount of 
certain molecules presents in a sample is of great importance to proteomics studies in 
the place where mass spectrometer applies to biological and medical sciences. 
MALDI is a soft-ionization technique that allows for vaporization and ionization of 
non-volatile samples from a solid phase directly into the gas phase, during soft 
ionization the molecules are not decayed into fragments, and thus, the mass of the 
intact molecule can be easily measured. The sample being analyzed is co-crystallized 
with a matrix chemical. The matrix chemical plays a key role by absorbing the laser 
energy and assists the sample ionization. This enables the use of lower laser energy 
and avoids the in-source decay of the sample. Once the sample molecules are 
vaporized and ionized, an electrostatic force then drives them into a time-of-flight 
MS where they are detected individually. Since the ionization and the travel of 
molecules are so direct and signal intensity is simply based on amount of molecules 
hitting the detector. In theory, the MALDI-TOF MS has the capability to quantify 
proteins. 
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Sample preparation is an important aspect for MS quantitative measurement. Direct 
mixing spotting method described for MALDI-TOF MS is to mix the analyte and 
matrix chemical (energy transferring molecules) in a suitable solvent and allow the 
analyte/matrix chemical mixture to dry and to co-crystallize on the metal surface of a 
sample plate (Karas and Hillenkamp 1988). During drying, the analyte molecules are 
incorporated with the matrix chemical to form crystals, and the formation of these 
crystals is extremely important for sample ionization. However, crystals formed in 
this way are highly variable and the presence of "sky-high" signal hot spots that 
produce saturating signals or spots with very weak signals are not uncommon. Spots 
formed by direct mixing method are good enough for proteins / peptides detection 
although the search for “ideal spots" is very time-consuming. For analyte 
quantification, a homogenous analyte-matrix chemical surface that enables efficient 
laser desorption is a prerequisite. This prevents the saturation of the detection system 
and also makes the results more representative. Moreover, if a non-homogenous 
surface is used, it will be very difficult to turn the system to automation. Limitations 
must be set to prevent the entry of saturating signals. 
Nitrocellulose was first used by Preston (Preston, Murray et al 1993) to improve the 
reproducibility of MALDI ion yield and also the precision of peptide quantification. 
He showed that nitrocellulose modifies the crystallization of analyte-matrix chemical 
solution and allows better coverage of the mixture over the sampling surface (Preston, 
Murray et al 1993). After his pioneer work, many researchers attempt to improve the 
reproducibility of the MALDI-TOF MS. Techniques like adding co-matrix chemicals 
to form a binary matrix chemical combined with accelerated drying (Domin, Welham 
et al 1999), electro sprayed sample preparation (Verhaert, Uttenweiler-Joseph et al. 
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2001), sampling on polytetrafluoroethylene surfaces (Rotting 2003) and preparations 
based on fast evaporation methods (Vorm and Roepstorff 1994) were investigated 
during the last decade. However, some of these techniques are too complicated to be 
used or require special equipments. 
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5.1 Evaluation of Different Matrix Chemical and 
Sample Spotting Techniques 
5.1.1 Effect of CHCA and SA 
How different types of sample spotting methods and matrix chemical affected 
ionization and reproducibility of MALDI-TOF MS were evaluated in this study. 
CHCA assists ionization in both high and low-molecular weight proteins although its 
performance decreases with increasing molecular weight of an analyte. In this study, 
mouse IgG (148.5 kDa) could only be detected in one of the trials. SA was only 
useful in high-molecular weight analyte and no signal was detected when applied to 
peptide samples. This observation is consistence with the work of Beavis (Beavis and 
Chait 1990). They showed that SA was not a good matrix chemical for samples in the 
peptide range. It is interesting to note that in the case of SA, even when using 
sandwich spotting method, the reproducibility of ion formation is not good enough 
for protein quantification. It is suggested that the mechanism of crystal formation of 
SA with the analyte is different to that of CHCA and is not suitable for protein 
quantification. 
Use of binary matrix chemical was first suggested by Domin (Domin, Welham et al 
1999), he mixed 2-(4-hydroxyphenzlazo) benzoic acid and 2-mercaptobenzothiazole 
in 1:1 (v/v) ratio. In the current study, CHCA and SA mixture (1:1, v/v) was tested. 
No calculable signal was obtained neither in the high-molecular weight protein nor in 
the peptide range, regardless of the spotting methods. May be crystals formed in this 
way are not good in energy transfer, hence, no signal is detected. 
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5.1.2 Effect of Nitrocellulose in Peptide Ions Formation 
NC was firstly used by Preston et al (Preston, Murray et al. 1993) in the sample 
preparation of MALDI-TOF MS. They observed that, addition of NC increased the 
yield of peptide ions, and improved the sample-to-sample reproducibility and the 
precision of peptide quantitation. Their observations are consistent to the results of 
this study. 
In the conventional sample-matrix chemical spotting methods, it is well known that 
the sizes of sample-matrix chemical co-crystals are highly variable. Optical 
microscopy results suggest that the NC can modify the crystallization process of 
sample-matrix-chemical solution to allow more even coverage over the sample stage 
surface (Preston, Murray et al 1993)�I t is possible that a thin NC coating film 
provides a "crystallization network" or "crystallization cores" for the formation of 
protein-matrix chemical co-crystals. Higher concentration of NC solution creates a 
denser network, and provides more crystallization cores for the formation of a layer 
of more homogenous small sample-matrix chemical co-crystals, resulting in more 
homogenous relative peptide ion signals. 
In general, when using NC as coating material, some of the proteins may become 
more difficult to ionize and were not detected. NC concentrations of 0.01% to 3% 
were tested in initial experiments and it was found that increasing concentration of 
nitrocellulose significantly reduced the signal intensity (data not shown). This 
observation is similar to the findings of Miliotis et. al. (Miliotis, Marko-Varga et al. 
2001). They co-crystallized matrix chemical and analyte with a variety of NC 
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concentrations. They observed that when NC concentration exceeds 0.5%, there is a 
significant reduction in signal to noise ratio in peaks. It is suggested that some of the 
analytes may physico-chemically bind to the nitrocellulose network (e.g. by 
non-covalent molecular binding forces, such as hydrophobic interactions, hydrogen 
bonding, and electrostatic interactions), and / or a too dense nitrocellulose network 
prevents energy transfer. The effect of NC concentration higher than 0.1% was not 
further investigated. 
Although using NC may reduce the signal intensity and the sensitivity of the 
detection system, it helps to improve the signal reproducibility as well as the 
precision of peptide quantification. Different concentrations of NC were tested. Too 
low NC concentrations (0.01% and 0.05%) are ineffective in forming a 
crystallization network for the co-crystallization of the matrix chemical and analytes 
while too high concentration (> 1%) inhibits ionization process. The results 
demonstrate that using 0.1% concentration NC as coating material and using 
sandwich spotting method with CHCA as energy transfer medium gave good 
reproducibility results. 
Low CV values in inter-assays and intra-assays were observed. The NC was 
dissolved in a highly evaporating solvent (mixture of acetone and isopropanol). It 
dries up quickly and the NC formed a fine, homogenous and evenly distributed 
network over the metal sampling surface. The NC network allows the matrix 
chemical to crystallize to similar size, and assist in even distribution of the crystals 
over the metal surface. These factors are especially important when developing 
automated MS detection programs to reach high-throughput standard and also to 
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folly utilize the potential of the MALDI-TOF MS. If the crystals in the spots are 
homogenous enough, the rate-limiting steps of searching for "ideal spots" can be 
avoided. Also, the presence of "sky-high signal" hot spots, the signals of which 
saturate the detector can be avoided. 
Regarding the direct mixing and overlaying sample spotting methods, it is believed 
that, the sample-matrix chemical co-crystals were of variable sizes and did not form 
evenly onto the sample plate surface. The non-homogenous sample layer formation 
might result the proteins / peptides that unevenly distributed in the co-crystals with 
various sizes. Biased measurements would then occur, thus, resulted in poor CV 
values. 
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5.2 MS Automation and High-Throughput Sampling 
An automated MS program was developed in the study. It scans 104 different 
positions within the sample spot area of 3.14 mm^ in a pre-defined automatic spiral 
motion. Different spiral detection pathway can be defined, so it is possible to acquire 
signal many times from the same spot by different acquisition protocol without 
ionizing the same sample-matrix co-crystal twice. This provides enough detections to 
average out signal variations (3,640 scans totally). 
It was observed that peaks with good signal to noise ratio could be generated from all 
over the sampling surface, and it was not necessary to search for any hot spots. There 
are no biases or limitations in signal detection and all the spectra were accumulated 
to form a single spectrum, so the final spectrum is a good representative of the 
analyte within a single spot. Two different modes of acquisition were used. One is for 
low-molecular weight proteins and peptides (900 Da to 12,000 Da) while the other 
one is for high-molecular weight proteins (10,000 Da to 200,000 Da). 
The major difference between the protocols is the delay time. Longer delay time is 
necessary for high-molecular weight analytes. Two acquisition protocols are used to 
achieve better resolution for the proteins in high and low-molecular weight ranges. 
The sampling plate used in the current study has a capacity for 100 different samples. 
With the automated detection protocol, a hundred different samples, therefore, can be 
analyzed automatically within hour(s). 
113 
5.3 Reproducibility and Signal Quantitations 
The reproducibility of ion formation by the MALDI-TOF MS was reflected in the 
inter-assay and intra-assay errors. When using 0.1% NC as the coating material, and 
sandwich spotting method with CHCA as the matrix chemical, the CV values are 
usually less than 15%, which indicates a good reproducibility in ion formation. 
The ability of MALDI-TOF MS in peptide quantification was demonstrated. When 
using homogenous preparation and sandwich spotting methods, a linear relationship 
between peptide quantity and relative signal was observed. The results demonstrated 
that the MALDI-TOF MS could be use as a platform to assay peptide quantity in 
very small amount of samples at low pmole level. 
In the accuracy of mass measurement, the percentage errors for all the tested peptides, 
ranged from 900 Da to 6,000 Da, were less than 0.05%. All the CVs were less than 
0.03% (TABLE 8). These data suggest that the introduction of NC layer does not 
significantly affect the mass accuracy of MALDI-TOF MS. 
There are limited reports that examined the quantitative ability of MALDI-TOF MS 
for proteins / peptides. In this study, the peak area of only one specific reference 
peptide was used for the calculation of relative level of an interested protein / peptide 
in serum sample. In order to improve the CVs and standardization of the results for 
further studies, multiple reference peptides might be used when profiling proteins / 
peptides in different mass ranges. It is also possible that the peak area of individual 












5A Peptidomics: The Study of Entire Peptidome 
One of the major limitations of the proteomics techniques is that proteins of mass 
less than 10 kDa are generally not retained and overlooked in most studies. For 
example, small proteins are very difficult to focus in lEF gels because they have very 
high mobility. In addition, peptides are difficult to stain in gels and, in most cases 
only very few faint spots can be visualized. Usually the quantity of peptide samples 
is very limited, and very high sensitivity techniques have to be used. Examples of 
proteins in the lower mass range are peptide hormones and neurotransmitters. They 
carry very valuable information about the physiological and pathological states of the 
human subject, thus study of these small proteins are very meaningful. 
Peptidomics is an analog of the proteomics. It is the analysis of the entire peptidome 
of a tissue, cell or body fluid at the amino acid level. One of the major objectives of 
this study is to develop a methodology that can be used as supplementary technique 
like 2-DE to capture proteins and peptides of the lower mass range. MALDI-TOF 
MS is a very good tool to study peptidomics because of its high sensitivity. It also 
allows the detection of proteins and peptides with very high or low pi values. 
Moreover, the high resolution of the MALDI-TOF MS allows clear separation of 
peptides with very similar molecular weights. Besides, unlike 2-DE, the 
hydrophobicity of the sample does not affect sample separation and detections. In 
addition, MALDI-TOF MS has no bias in identifying known or unknown proteins. 
Detection of proteins / peptides samples is simple and straightforward. 
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5.5 Serum Peptides 
Blood and lymph are the major links between organs, tissues and cells. Serum 
contains the representative collections of peptides, proteins and protein fragments 
that are produced from the entire body. Blood samples have vital clinical and 
scientific importance. Most of physiological changes are reflected in the blood 
rapidly. Blood collection is simple, safe, non-invasive, and the samples can be 
collected any time to follow physiological changes. In addition, collection and 
storage procedures of blood samples are well defined. In order to apply the 
methodology into real situation, serum samples were subjected to MALDI-TOF MS 
quantification in this project. 
The identification of serum peptides and proteins with regulatory functions are very 
difficult because they are usually present in very low concentrations, and in some 
cases, they form complexes with high abundant housekeeping proteins. In addition, 
the presence of high abundant housekeeping proteins will suppress the MS signal of 
low abundant regulatory proteins, causing the difficulties in their discovery. 
Moreover, serum proteins are so dynamic and vary from individual to individual and 
from time to time. Many false positive regulatory protein candidates may be 
identified. Initial efforts have been made to quantify serum proteins directly but were 
failed to generate any calculable signals. 
To modify the test, three factors were taken into consideration. First to remove high 
abundant proteins, and second to inactive the biological activities of the serum before 
any measurement took place. Also an internal standard is necessary for quantification, 
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Since the high abundant housekeeping proteins, such as albumin and 
immunoglobulins, are relatively large proteins and they can be easily removed by 
size-exclusion techniques. The biological activities of the samples can be inactivated 
with strong acid. Commercially available peptide standards were added to the same 
to serve as internal standards. Therefore, a simply and quick-size-exclusion method 
was developed. The serum was first inactivated with a strong acidic solution (1% 
TFA, pH 1.0) and peptide standards were added. Afterwards, the solution mixture 
was passed through a 30 kDa cutoff filter. High-molecular weight house-keeping 
proteins were removed, and signals of low-molecular weight proteins and peptides 
were enhanced. As demonstrated in the initial experiments, the CHCA sandwich 
spotting method is very useful to quantify proteins in the peptide range. Although 
some high-molecular weight regulatory proteins may be lost by this method, it is 
very effective in reducing sample complexity and allows effective ionization of 
low-molecular weight proteins. 
118 
5.6 Application of Peptidomics to Discover Markers 
for HCC 
5.6.1 Hepatocellular Carcinoma 
Hepatocellular carcinoma is a primary liver cancer. HCC is the fifth most common 
cancer in the world (Akriviadis, Llovet et al 1998; Schafer and Sorrell 1999; Okuda 
2000). As a deadly cancer, HCC kills almost all patients who have it within two 
years. About three quarters of the HCC cases are found in Southeast Asia (China, 
Hong Kong, Taiwan, Korea, and Japan). HCC is also very common in sub-Saharan 
Africa (Mozambique and South Africa). Its incidence is increasing in the United 
States and other countries. 
5.6.2 Causes of HCC 
The pathogenesis of HCC is associated with chronic hepatitis virus (Hepatitis B and 
Hepatitis C vims) inflection, and exposure to carcinogenic agents such as aflatoxin 
B1 (Stuver 1998). Aflatoxin B1 is a product from fungus called Aspergillus flavus, 
which is found in food that has been stored in a hot and humid environment. This 
fungus is found in food such as peanuts, rice, soybeans, com, and wheat. Liver 
cirrhosis is also associated with HCC (Bosch and Munoz 1988; Benvegnu and 
Alberti 2001). The chronic inflammation and cell damage in a cirrhotic liver may 
have provided the proliferative stimulus for hepatocellular carcinoma (Seow, Liang 
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et al. 2001). Excess alcohol intake is also a risk factor for HCC development (Chiesa, 
Donato et al. 2000). 
5.6.3 HCC Tumor Markers 
Tumor markers are broadly defined as biomolecules that can be quantified in body 
tissues or body fluids. Tumor markers are especially important for clinical use and 
help to detect disease in early stages. Good tumor markers are highly specific 
sensitive. They are useful for screening, staging, prognosis, monitoring treatment 
response and detection of tumor recurrence (Diamandis, Okui et al 2002). It is also 
important for understanding the development of cancer and the physiological 
changes behind. Much effort has been made to identify tumor markers for HCC but 
most of the identified markers were proved less successful because they are either of 
low specificity, low sensitivity or too complicated to be used as a clinical test. HCC 
serum tumor markers are so difficult to identify because, in ideal case, it should not 
be affected by factors like hepatic regeneration, liver function and cirrhosis. 
Moreover, the best tumor marker should originate from the tumor itself directly but 
not by any secondly effects. 
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One of the most widely used tumor markers for HCC diagnosis is the 
alpha-fetoprotein (AFP) (Johnson, Portmarm et al. 1978;-Sheu, Sung et al. 1985; 
Nomura, Ohnishi et al 1989). AFP is a plasma glycoprotein consisting of 591 amino 
acids that is normally produced by the fetus. AFP is manufactured principally in the 
fetus's liver and, also, in the fetal gastrointestinal (GI) tract and the yolk sac, a 
structure temporarily present during embryonic development. The level of AFP is 
typically high in the fetus丨 blood and drops gradually after birth. It is virtually 
undetectable after one year of birth. About 70% of HCC patients have AFP levels 
above the reference range (Johnson, Portmarm et al 1978; Sheu, Sung et al. 1985; 
Nomura, Ohnishi et al. 1989). Serum AFP concentration higher than 500 ng/mL 
indicates that the patient is at risk of HCC. This level is usually used as clinical 
reference for HCC diagnosis because moderate level of AFP (10 ng/mL to 500 
ng/mL) are also common in non-malignant CLD. This indicates that the specificity of 
the AFP test is not enough (Johnson, Portmarm et al 1978; Okuda 1986; Lok and Lai 
1989). This is a major disadvantage of the test since most cases of HCC arise in 
patients with concurrent CLD (Kew and Popper 1984; Johnson and Williams 1987). 
When the level of AFP falls into the “grey area” (10 ng/mL to 500 ng/mL), 
differentiation between benign and malignant liver becomes difficult, and judgment 
cannot be made with AFP level alone. Recently, there are attempts to increase the 
specificity of the AFP test. Different glycoforms of HCC specific AFP were 
identification and quantified (Johnson, Poon et al. 2000; Poon, Mok et al. 2002). 
Novel tumor markers for HCC has also been discovered, these include a 1-antitrypsin 
(AlAT) (Hong and Hong 1991); thyroxin-binding globulin (TBG) (Alexopoulos, 
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Hutchinson et al 1988; Huang and Liaw 1990); des-gamma-carboxy prothrombin 
(Mita, Aoyagi et al 1998); transferrin (Suzuki, Aoyagi et al 1996); and transforming 
growth factor (Tomiya and Fujiwara 1996). However, none of these markers are 
specific or sensitive enough to be used alone to identify all the HCC cases. Therefore, 
it is necessary to identify highly specific HCC tumor markers with good sensitivity to 
meet clinical needs. 
5.6.4 HCC Tumor Markers Identified in the Current 
Studies 
Low-molecular weight serum proteins reflect the pathological stage of the individual 
and also aid in the early detection of diseases. Recently, there are many research 
groups showing their achievements in identifying low-molecular weight disease 
markers. Low-molecular weight protein disease markers were identified in ovarian 
cancer (Petricoin and Liotta 2002); prostate cancer (Adam, Qu et al. 2002); HCC 
(Poon, Yip et al. 2003); pancreatic ductal adenocarcinoma (Rosty, Christa et al. 
2002); and breast cancer (Paweletz, Trock et al. 2001; Li, Zhang et al. 2002). In 
order to identify if there are any low-molecular weight markers for HCC, comparison 
was made between peptide profiling of pooled serum from different subgroups of 
HCC cases (AFP concentrations larger than or less than 500 ng/mL). Peptides 
profiling from CLD pooled serum, and comparison was also made between sera from 
individuals. It was found that the peak at m/z 1,466 is specific for HCC cases. Peaks 
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at m/z 1,772, 2,442 and 2,763 are dominant features of CLD cases. Unlike the 
features of HCC, CLD distinguishing features are less specific and they cannot be 
used alone to distinguish CLD from HCC cases. These potential features have 
moderate to high specificity but the sensitivity is not very good. This means that, 
high accurate classifications cannot be carry out by using single feature. 
To apply the above findings to identify HCC cases, bioinformatics and biostatistics 
tools are necessary. Recently, classification tree and neural network algorithms are 
applied to improve the sensitive and specificity of tumor markers (Poon and Johnson 
2001; Xu and Adak 2002). In the current investigation, some of the features are 
highly specific for HCC or CLD but only with moderate sensitivity. To improve the 
overall performance, classification tree modeling was used. It aimed to identify the 
best model. Three different models were generated from the same set of potential 
features and with or without including AFP levels. 
It was found that using serum maker level with serum AFP level generated the best 
model to classify HCC and CLD cases. The model has 94.4% sensitivity, 83.3% 
specificity and 90.7% accuracy. When compared to the performance of single 
distinguishing features, the classification model makes better use of the features and 
improves the overall performance of the test. The classification tree serves to give an 
easy and useful guide for clinical use. It is interesting to note that, although the same 
set of features was used for construct classification tree, different features were 
selected in different models, and feature 1,772 m/z was the only one used by all the 
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three models. The ability of the models to distinguish HCC and CLD cases can be 
improved by using larger number of teaching samples and input more variables in the 
fixture studies. Distinguishing features identified in the current studies together with 
the classification tree model can assist the conventional AFP test to classify HCC and 
CLD cases. 
Relationships between the four features in HCC and CLD group were analyzed by 
the Spearman's rank order test, only the pair 2,442 m/z with 2,763 m/z showed 
positive relationship. It is possible that there may be more distinguishing features 
undiscovered and these features may be able to link up the markers together. 
To identify the component in the distinguishing features, high resolution MS that has 
the ability to sequence peptides is necessary. In the case of the MALDI-TOF MS, 
PSD (Kaufmann, Spengler et al. 1993) may also help to identify the component. 
After identification, ELISA can be developed to simplify the detection procedures 
and allows the test to perform in clinic laboratories with minimum instrument 
demands. 
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5,7 Role of MALDI-TOF MS, SELDI-TOF MS and 
2-DE in Peptidomics 
A recently developed technique is the SELDI-TOF MS, it is one of the most useful 
instrumentation that can profile both proteins and peptides (0.5 kDa to 200 kDa) 
(Poon, Yip et al 2003). SELDI-TOF MS combines chromatography and MS. The 
ProteinChip™ of the SELDI-TOF MS is modified either chemically (e.g. reverse 
phase (H4), metal ions (IMAC3), hydrophobic (CI8), hydrophilic (SiOi), anionic 
(SAX2), cationic (WCX2), etc) or biochemically (cell receptors, antibodies, enzymes, 
substrates for enzymes, DNA, and etc). The ProteinChip'^^ surface can retain specific 
kind of proteins while unbounded proteins and contaminants are washed away. The 
molecular weights of the retained proteins can then be measured by the TOF MS. 
There are increasing number of successful examples using the SELDI-TOF MS to 
identify disease markers including those for ovarian cancer (Petricoin, Ardekani et al 
2002), prostate cancer (Adam, Qu et al. 2002); HCC (Poon, Yip et al 2003), 
pancreatic ductal adenocarcinoma (Rosty, Christa et al 2002), and breast cancer 
(Paweletz, Trock et al 2001; Li, Zhang et al 2002) are some of the representative 
examples. The application of SELDI-TOF MS is so successful because 
(1) SELDI-TOF MS has the ability to reduce the complexity of the sample; 
(2) it is sensitive and (3) it is quantitative (Paweletz, Gillespie et al 2000; Paweletz, 
Trock et al 2001). 
The present study has demonstrated that the MALDI-TOF MS also has the capability 
to quantify proteins and peptides in a reproducible way. The CV values of the current 
method are similar to those obtained by the SELDI-TOF MS (manufacturer's 
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information from Ciphergen). This means that, after reducing sample complexity, the 
MALDI-TOF MS can be used as a platform to quantify peptides, and is a useful tool 
to discover disease markers. In fact, the TOF MS and the laser ionization unit of the 
SELDI and the MALDI are very similar. Both instruments have their merits and 
demerits. 
MALDI-TOF MS is able to operate in reflector mode, and has higher resolving 
power than the SELDI-TOF MS. Thus, MALDI-TOF MS has the ability to perform 
partial peptide sequencing by PSD (Kaufmann, Spengler et al. 1993). However the 
TOF tube of the SELDI-TOF MS is usually shorter than that of the MALDI-TOF MS, 
and hence fewer ions will be lost, resulting higher sensitivity. 
The SELDI chip is more user-friendly as it requires less preparative work and the 
quality of the chip is well controlled. Moreover, it is convenient to fractionate, bind, 
wash, and detect samples on the same chip. In addition, the SELDI chip provides 
some flexibility for selecting different types of sample with different chemical or 
biochemical properties. SELDI provides a very effective way to reduce sample 
complexity and also to minimize effort for data analysis. Furthermore, it was 
demonstrated that, the detection range of the SELDI-TOF MS is larger than that of 
the MALDI-TOF MS, it enables effective quantification of proteins of molecular 
weight up to 200 kDa (Poon, Yip et al 2003). The SELDI-TOF MS itself is already a 
comprehensive tool for proteome analysis. It can perform sample separation, 
molecular weight measurement and quantification. 
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MALDI-TOF MS, however, usually acts as a component of the detection system. It 
aids to identify proteins after 2-DE, HPLC or other complicated purification 
techniques. It seldom acts as an independent unit in proteome analysis. The cost of 
running a MALDI-TOF MS is cheaper than a SELDI-TOF MS. The MALDI sample 
plate can be reused from time to time but the SELDI chip is only good for a single 
assay. Although compared to the SELDI system, there are more limitations in the 
MALDI-TOF MS in protein quantification. The major advantages of our approaches 
are easy to perform, low cost, automatic, high throughput and quantitative. Our 
system is useful for detecting disease markers or to do quick screening. The findings 
are particularly useful for those laboratories that equipped with MALDI-TOF MS as 
their only MS system. 
2-DE has been used for more than 25 years (Klose 1975; OTarrell 1975). It has 
high-resolution separation ability and good sensitivity. The samples are separated 
according to their pi values in the first dimension, and according to their molecular 
weights in the second dimension. Quantification of proteins depends on staining 
methods, scanners and the computer software. As there are gel to gel variations, it is 
sometimes difficult to tell the true differences between the experimental and control 
group. Another disadvantage is that peptides are always missed in 2-DE analysis. 
However peptides are important indicators of the pathological state of the subject, 
and may aid in the detection of diseases. Moreover, peptides are very difficult to 
focus in lEF gels. In addition, 2-DE is very labor intensive. It is difficult to handle a 
lot of gels at the same time. 2-DE requires relative large amount of samples and low 
abundant proteins are often not detected. The advantage is that isoforms of proteins 
are often easily identified in 2-DE. It gives a comprehensive picture about the 
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proteome of the sample with certain information about the mass, pi values, relative 
abundances, post-translational modification. 
In fact, the current method can compensate the disadvantage of 2-DE in profiling 
small proteins and peptides. For example, samples for 2-DE can be fractioned with a 
ten kDa cutoff filter. The high-molecular weight protein fraction is subjected for 
2-DE analysis while the low-molecular weight peptide fraction is subjected for direct 
MALDI-TOF MS quantification. 
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C H A P T E R 6 CONCLUSION 
In the present project, a simple and quantitative approach has been developed for 
peptidomic profiling and quantification with the use of unbiased automatic 
MALDI-TOF MS acquisition methods. The effects of spotting methods and energy 
absorbing reagents have been systemically evaluated. It was found that coating the 
sample plate surface with 0.1% NC combined with sandwich spotting method and 
the use of CHCA as matrix chemical (energy transfer material) gave the most 
reproducible quantification results. By using commercially available peptide 
standards, the quantitative capability of this NC-MALDI-TOF MS approach was 
successfully demonstrated in this project. The normalized signal intensities of the 
proteins / peptides were directly proportional to their concentration with intra-assay 
(within-day) CVs between 6.5% and 17%. 
Using the NC-MALDI-TOF MS approach, a simple method for quantitative profiling 
of serum peptides was developed. About 100 peptides can be identified and 
quantified in a serum sample. This approach can reliably quantify the peptides 
(< 6,000 Da) in serum samples with inter-assay (between-days) CVs less than 15%. 
Subsequent analyses of the serum peptidomic profiles in the HCC and CLD patient 
groups identified four peptides of 1,466 Da; 1,772 Da; 2,442 Da; and 2,763 Da, 
which are the potential biomarkers for differentiating between HCC and CLD cases. 
A classification tree based on the serum levels of the 1,466 Da peptide; the 1,772 Da 
peptide; the 2,763 Da peptide; and AFP was developed, and could classify the HCC 
and CLD cases with high accuracy (91%). It is noteworthy that most of the HCC 
cases with non-diagnostic AFP levels were correctly classified. 
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In conclusion, a method for serum peptidomic profiling with the use of MALDI-TOF 
MS was successfully developed, and subsequently was shown to be useful in the 
identification of serum peptides of potential clinical values in the diagnosis of HCC. 
This study suggests the possibility of a general approach to the screening and 
identification of tumor-specific serum peptidomic pattern in a high-throughput 
manner. 
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